Clinical Publications
| SR. NO. | NAME OF PUBLISHED ARTICLE | LINKS | SUMMARY | JOURNAL AND YEAR OF PUBLICATION | NUMBER OF PATIENTS | STUDY DESIGN | FOLLOW-UP | FIRST AUTHOR |
|---|---|---|---|---|---|---|---|---|
| Total Publications= 467 | ||||||||
| CARDIOVASCULAR (Total = 386 articles) | ||||||||
| Myval™ Transcatheter Heart Valve Replacement-Clinical Publications (Total = 233 articles) | ||||||||
| Original Research Articles (78) | ||||||||
| OR 78 | Pacemaker recovery after permanent pacemaker implantation post-transcatheter aortic valve implantation: A sub-study of the LANDMARK trial | Summary | Know More | International Journal of Cardiology (2024) | 384 of 768 patients | Post-hoc sub-study of the LANDMARK trial (prospective, multicentre, open-label, noninferiority trial) | 1-year | Akihiro Tobe, Ireland |
| OR 77 | Early Echocardiographic Changes Following Transcatheter Aortic Valve Implantation: A Comparative Analysis of Different Transcatheter Aortic Valve Systems | Summary | Know More | Journal of Cardiovascular Development and Disease (2026) | 22 of 332 patients | Retrospective, single-center observational study | Post-procedure | Huseyin Dursun, Turkey |
| OR 76 | Single Centre Experience With the Balloon‐Expandable Myval Transcatheter Aortic Valve System in Patients With Bicuspid Anatomy: 1 Year Follow‐Up | Summary | Know More | Catheterization and Cardiovascular Interventions (2026) | 52 patients | Retrospective, single-centre, real-time study | 30-day and 1-year | Balázs Magyari, Hungary |
| OR 75 | Myval Octacor and Octapro Trans-Catheter Heart Valves in Patients with Severe Pure Non Calcified Native Aortic Regurgitation | Summary | Know More | IJC Heart & Vasculature (2026) | 32 patients (Myval Octacor: 21; Myval Octapro: 11) | Retrospective cohort analysis | In-hospital, 30-day, and 1-year | Alfonso Ielasi, Italy |
| OR 74 | Safety and effectiveness of balloon-expandable Myval transcatheter aortic valve implantation: a single-center, real-world evidence from Kazakhstan | Summary | Know More | Journal of Cardiothoracic Surgery (2026) | 100 patients | Retrospective, observational, single-arm and single-center study | 30-day | Abdurashid Mussayev, Kazakhstan |
| OR 73 | Real-world procedural and clinical outcomes of contemporary balloon-expandable and self-expandable TAVR systems: a single-center experience | Summary | Know More | Frontiers in Cardiovascular Medicine (2026) | 41 of 366 patients | Retrospective consecutive registry | Intra- and post-operative | Mattia Vinciguerra, Italy |
| OR 72 | TAVI Performance at a Single Center over Several Years: Procedural and Clinical Outcomes | Summary | Know More | Medicina (2026) | 25 of 375 patients | Retrospective study | 30-day, 1-year, and 5-year | Huseyin Dursun, Turkey |
| OR 71 | Performance of XL Sizes of Myval Balloon-Expandable Valve in Real-World Patients with Extremely Large Aortic Annuli | Summary | Know More | Medicina (2026) | 15 patients | Retrospective, observational study | Discharge, 3-6 months, 1 year | Kasparas Briedis, Lithuania |
| OR 70 | Early Outcomes of the Myval Octacor Transcatheter Heart Valve in Transcatheter Aortic Valve Implantation: A Single-Center Study From Serbia | - | Know More | The Journal of Invasive Cardiology (2026) | 43 patients | Retrospective, observational study | Procedural, post-procedure and 30-day | Procedural, post-procedure and 30-day |
| OR 69 | Left Ventricular Ejection Fraction in Patients Undergoing Transcatheter Aortic Valve Implantation Insights From the COMPARE-TAVI-1 Study | Summary | Know More | JACC: Advances (2026) | 1,029 Patients | Prospective, multicenter, randomized controlled trial, all-comers | 30-days and 1-year | Preman Kumarathurai, Denmark |
| OR 68 | Paradoxical Normal‐Flow Aortic Stenosis Despite Reduced Left Ventricular Ejection Fraction: Insights From the Randomized COMPARE‐TAVI 1 Trial | Summary | Know More | Journal of the American Heart Association (2026) | 979 patients | Prospective, multicenter, randomized controlled trial | 30 Days and 1 year | Emil Johannes Ravn, Denmark |
| OR 67 | One-year outcomes of novel balloon-expandable versus contemporary transcatheter heart valves in severe aortic stenosis: the LANDMARK trial | Summary | Know More | Journal of the American College of Cardiology (2026) | 768 patients | Prospective, randomized, open-label, non-inferiority trial | 1 year | Patrick W. Serruys, Ireland |
| OR 66 | Early‐Term Outcomes of Percutanous Pulmonary Valve Implantation With the Meril's Myval Pulmonary Valve— Single Center Experience From Turkey | - | Know More | Catheterization and Cardiovascular Interventions (2025) | 124 patients | Retrospective, single-center stud | 1.6-year (median follow-up) | Alper Guzeltas, Turkey |
| OR 65 | Early-term results of percutaneous pulmonary valve implantation (valve-in-valve) in dysfunctional bioprosthetic valves in pulmonary position | Summary | Know More | Turkish Journal of Thoracic and Cardiovascular Surgery (2025) | 11 of 20 patients | Retrospective, single-center study | 24.8 months (median follow-up) | Ensar Duras, Turkey |
| OR 64 | Three-Year Follow-Up of the First 100 Patients Treated with the Balloon-Expandable Myval Transcatheter Aortic Valve System: ASingle-Centre Experience OR 64 Journal of Clinical Medicine (2025) 100 patients Retrospective, single-centre study 30 days, 1,2 and 3 years Balázs Magyari, Hungary OR 63. Association between aortomi | Summary | Know More | Journal of Clinical Medicine (2025) | 100 patients | Retrospective, single-centre study | 30 days, 1,2 and 3 years | Balázs Magyari, Hungary |
| OR 63 | Association between aortomitral continuity calcification and conduction disturbances following transcatheter aortic valve implantation with the balloon- expandable | Summary | Know More | Journal of Arrhythmia (2025) | 160 patients | Retrospective study | 30 days | Serkan Aslan, Turkey |
| OR 62 | Early outcomes of Myval™ Octacor transcatheter pulmonary valve implantation in dysfunctional right ventricular outflow tract conduits and pulmonary valve bioprostheses: a single-centre UK experience | - | Know More | Cardiology in the Young (2025) | 10 patients | Retrospective, single-centre study | 1, 3, 6, and 12 months | Mohammed Kamal Badawy, UK |
| OR 61 | Cardiac damage and outcome in transcatheter aortic valve replacement patients – a COMPARE-TAVI 1 trial sub-study | Summary | Know More | Oxford University Press (2025) | 985 | Multicenter, prospective, randomized controlled trial | 30 days and 1 year | Rasmus Carter-Storch |
| OR 60 | Impact of Flow-status on Effective Orifice Area in 3 Transcatheter Heart Valves: a COMPARE-TAVI 1 Sub study | Summary | Know More | Journal of the American Society of Echocardiography, 2025 | 507 out of 1031 patient | Multicentre, all-comers, randomized, non-inferiority trial | 30-days | Lytfi Krasniqi |
| OR 59 | Quantitative videodensitometric assessment of aortic regurgitation in Myval, Sapien, and Evolut THV series: Results from the LANDMARK trial | Summary | Know More | IJC Heart & Vasculature (2025) | 596 Patients | Post-hoc analysis | Post-procedural | Elfatih A. Hasabo, Ireland |
| OR 58 | A comparison of transcatheter aortic valve prosthesis platforms: Myval, Sapien, and Evolut in severe symptomatic aortic stenosis and low moderate risk patients | Summary | Know More | Radiology and Oncology (2025) | 97 out of 1053 patients | Prospective, randomised, multinational, open-label non-inferiority trial | 30 Days and 1 year (10 Year follow-up) | Matjaz Bunc, Slovenia |
| OR 57 | Balloon‐Expandable MyVal Octacor Versus Self-Expanding Evolut PRO/PRO+ and Accurate Neo2: Short‐Term Outcomes From Propensity‐Matched Analysis | Summary | Know More | Catheterization and Cardiovascular Interventions (2025) | 252 out of 2475 patients | Prospective multicentre international registry | 30 Days | Elisabetta Moscarella, Italy |
| OR 56 | Comparative 30-day Echocardiographic Outcomes of MyVal versus Sapien and Evolut THVs: Insights from LANDMARK Trial | Summary | Know More | European Heart Journal (2025) | 768 patients | Prospective, randomised, multicentre, open-label, non-inferiority trial | 30 Days | Osama Soliman, Ireland |
| OR 55 | Head-to-Head Comparison of Meril Myval Series Balloon-Expandable and Abbott Portico Series Self-Expanding Transcatheter Aortic Valves—A Single-Center Experience | Summary | Know More | Medicina (2025) | 97 of 144 patients | Retrospective, all-comers, single-center observational registry | 30 Days and 1 Year | Matjaž Bunc, Slovenia |
| OR 54 | Comparison of Self-Expandable Accurate Neo-2 and Balloon-Expandable MyVal Transcatheter Heart Valves at 4-Year Follow-Up | Summary | Know More | Catheterization and Cardiovascular Interventions (2025) | 401 of 545 patients | Multicenter retrospective analysis | 4 Years | Akash Jain, Spain |
| OR 53 | Early Conduction Abnormalities Following Trans Catheter Aortic Valve Implantation In Al Najaf Cardiac Center: Single-Center Experience From Iraq | Summary | Know More | African Journal of Biomedical Research (2025) | 121 of 213 patients | Single-center, observational cohort | In-hospital and periodic FU | Ammar Jabbar Majeed, Iraq |
| OR 52 | "Four-year durability of the MyVal balloon-expandable transcatheter aortic valve" | Summary | Know More | Euro Intervention (2025) | 366 patients | Ambispective multicenter study | 30 Days, 1 and 4 Years | Akash Jain, Spain |
| OR 51 | Single‐Center Evaluation of the Myval Balloon‐Expandable Transcatheter Heart Valve: A Follow‐Up Study: A Retrospective Cohort Study | Summary | Know More | Health Science Reports (2025) | 92 patients | Retrospective descriptive study | 3 Months | Mohammadreza Baay, Iran |
| OR 50 | Single-Centre Experience with the Balloon-Expandable Myval Transcatheter Aortic Valve System with the First 200 Patients: 30-Day and 1-Year Follow-Up | Summary | Know More | Journal of Clinical Medicine (2025) | 200 patients | Retrospective,single-centre, study | 30 Days and 1 Year | Bálint Kittka, Hungary |
| OR 49 | Immediate and Early Outcomes Following Myval Octacor Transcatheter Heart Valve Implantation for the Treatment of Patients With Severe Aortic Valve Stenosis: The OCTACOR‐EU Study | Summary | Know More | Catheterization and Cardiovascular Interventions (2025) | 252 patients | An observational, retrospective, multicenter, investigator‐driven registry | 30 Days | Alfonso Ielasi, Italy |
| OR 48 | "Percutaneous Pulmonary Valve Implantation In Native | Summary | Know More | Health Science Reports (2025) | 17 patients | Multicenter registry | "Immediate results of 30.5 and 32 mm MyVal™ valves implantation" | João Luiz Langer Manica, Brazil |
| OR 47 | SAPIEN 3 versus Myval transcatheter heart valves for transcatheter aortic valve implantation (COMPARE-TAVI 1): a multicentre, randomised, non-inferiority trial | Summary | Know More | The Lancet (2025) | 514 out of 1031 Patients | "Multicentre, all-comers, randomised, non- inferiority trial" | 1 Year | Christian Juhl Terkelsen, Denmark |
| OR 46 | The Myval Balloon-Expandable Transcatheter Heart Valve Implant in Aortic and Mitral Interventions: A Single-Center Experience | Summary | Know More | Cureus (2025) | 15 Patients | Retrospective single- cohort observational study | 22 Months | Ramesh Patel, India |
| OR 45 | Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals | Summary | Know More | EuroIntervention (2024) | 384 out of 768 Patients | Prospective, RCT | 30 Days | Niels van Royen, The Netherlands |
| OR 44 | A new and easy parameter to predict the requirement for permanent pacemaker implantation after transaortic valve implantation: aortic knob calcification | Summary | Know More | Advances in Interventional Cardiology (2024) | 110 Patients | Retrospective study | Post-procedure | Ahmet Özderya, Turkey |
| OR 43 | Learning Curve for Starting a Successful Single-Centre TAVR Programme with Multiple Devices: Early and Mid-Term Follow-Up | Summary | Know More | Journal of Clinical Medicine (2024) | 11 out of 122 Patients | Retrospective study | 3 Years | Balázs Magyari, Hungary |
| OR 42 | Performance of balloon-expandable transcatheter bioprostheses in inoperable patients with pure aortic regurgitation of a native valve: The BE-PANTHEON international project | Summary | Know More | Cardiovascular Revascularization Medicine (2024) | 41 out of 144 Patients | Retrospective study | 1 year | Enrico Poletti, Italy |
| OR 41 | Initial experience with the Myval balloon expandable valve in Argentina | Summary | Know More | Revista Argentina de Cardioangiología Intervencionista (2024) | 300 Patients | Prospective multi-center registry | Post-procedure | Federico Blanco, Argentina |
| OR 40 | Early Outcomes of Transcatheter Aortic Valve Implantation With Next-generation Balloon-expandable Myval Transcatheter Heart Valve: Single-center Experience From Iraq | Summary | Know More | Journal of the Saudi Heart Association (2024) | 100 Patient | Prospective single-centre study | 30 Days | Khalid Amber, Iraq |
| OR 39 | German Experience with a Novel Balloon-Expandable Heart Valve Prosthesis for Transcatheter Aortic Valve Implantation Outcomes of the MYLAND (MYvaL germAN stuDy) Study | Summary | Know More | Journal of Clinical Medicine (2024) | 134 Patients | Investigator-initiated, multi-center, retrospective, observational study | 30 Days | Timm Ubben, Germany |
| OR 38 | LANDMARK trial: Randomised non-inferiority comparison of early outcomes of newer generation Myval THV series with contemporary valves (Sapien and Evolut THV series) in real-world Patients with severe symptomatic native aortic stenosis | Summary | Know More | The Lancet (2024) | 768 Patients | RCT | 30 Days | Andreas Baumbach, UK |
| OR 37 | Clinical outcomes of the Myval transcatheter heart valve system in Patients with severe aortic valve stenosis: a two-year follow-up observational study | Summary | Know More | Archives of Medical Science (2024) | 207 Patients | Multi-centre, registry based, observational study | 2 Years | Teoman Kilic, Turkey |
| OR 36 | Multicenter Experience for Early and Mid-Term Outcome of MyVal Transcatheter Pulmonary Valve Implantation | Summary | Know More | Pediatric Cardiology (2024) | 53 Patients | Multi-center, observational study | 360 Days median follow-up | Mohamed Al Nasef, Saudi Arabia |
| OR 35 | Safety and effectiveness of the novel Myval Octacor transcatheter heart valve in severe, symptomatic aortic valve stenosis – A real world Indian experience (The OCTACOR India Study) | Summary | Know More | Cardiovascular Revascularization Medicine (2024) | 123 Patients | Multi-center, real-world observational registry | 30 Days | John Jose, India |
| OR 34 | Single-Center Experience with the Balloon Expandable Myval Transcatheter Aortic Valve System in Patients with Bicuspid Anatomy: Procedural and 30-Day Follow-Up | Summary | Know More | Journal of Clinical Medicine (2023) | 52 Patients | Retrospective, observational study | 30 Days | Balázs Magyari, Hungary |
| OR 33 | Clinical Outcomes Following Transcatheter Mitral Valve-in-Valve Replacement Using a Meril Myval Transcatheter Heart Valve | Summary | Know More | Heart, Lung and Circulation (2023) | 20 Patients | Retrospective, observational, single-centre study | 1 Year | Mullasari Ajit Sankardas, India |
| OR 32 | Clinical comparison of a novel balloon-expandable versus a self-expanding transcatheter heart valve for the treatment of Patients with severe aortic valve stenosis: the EVAL Registry | Summary | Know More | Journal of Clinical Medicine (2022) | 58 of 166 Patients | Retrospective, single-centre study | 6 months | Monica Barki, Italy |
| OR 31 | Single center experience with the balloon‐expandable Myval transcatheter aortic valve system with the first 100 Patients: 30‐day and 1‐ year follow‐up | Summary | Know More | Catheterization and Cardiovascular Interventions (2023) | 100 Patients | Retrospective, single-center study | 1 Year | Balázs Magyari, Hungary |
| OR 30 | Transcatheter Aortic Valve Replacement for Pure Native Aortic Valve Regurgitation: The PANTHEON International Project | Summary | Know More | JACC: Cardiovascular Interventions (2023) | 40 out of 69 Ballon expandable Patients | Retrospective study | 1 Year | Enrico Poletti, Italy |
| OR 29 | Performance of the 32 mm Myval transcatheter heart valve for treatment of aortic stenosis in Patients with extremely large aortic annuli in real- world scenario: first global, multi-centre experience | Summary | Know More | Catheterization and Cardiovascular Interventions (2023) | 10 Patients | Global Retrospective, observational multi-center study | 30 Days | Andreas Holzamer, Germany |
| OR 28 | Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation | Summary | Know More | EuroIntervention (2023) | 113 Patients | International, multi-center, observational study | 1 Year | Juan Pablo Sánchez-Luna, Spain |
| OR 27 | Early Outcomes of a Next- Generation Balloon-Expandable Transcatheter Heart Valve – The Myval System: A Single-Center Experience from Serbia | Summary | Know More | Journal of Cardiology and Cardiovascular Medicine (2023) | 13 Patients | Retrospective, single center study | 30 Days | Darko Boljevic, Serbia |
| OR 26 | Assessing the Novel Myval Balloon-Expandable Valve with the Evolut Valve: A Propensity- Matched Study | Summary | Know More | Journal of Clinical Medicine (2023) | 120 out of 223 Patients | Retrospective, single-center study | 1 Year | Jonathan Halim, The Netherlands |
| OR 25 | Angiographic quantification of aortic regurgitation following Myval Octacor implantation: Independent core lab adjudication | Summary | Know More | International Journal of Cardiology (2023) | Total 125 Patients (103 analyzable) | Retrospective, core lab analysis | - | Ahmed Elkoumy, Ireland |
| OR 24 | Safety and performance parameters of the Myval transcatheter aortic valve bioprosthesis: The SAPPHIRE prospective registry | Summary | Know More | Cardiovascular Revascularization Medicine (2023) | 100 Patients | Single-arm, prospective registry | 2 Years | Luca Testa, Italy |
| OR 23 | One-year outcomes after Myval implantation in Patients with bicuspid aortic valve stenosis-a multi-centre real-world experience | Summary | Know More | Journal of Clinical Medicine (2023) | 62 Patients | Retrospective multi-centre study | 13.5 months median follow-up | Ahmed Elkoumy, Ireland |
| OR 22 | Latest iteration balloon and self-expandable transcatheter valves for severe bicuspid aortic stenosis: The TRITON study | Summary | Know More | Revista Española de Cardiología (2023) | 122 out of 360 Patients | Multi-centre, retrospective registry | 30 Days | Ignacio J Amat-Santos, Spain |
| OR 21 | Transcatheter valve-in-valve or valve-in-ring implantation with a novel balloon-expandable device in Patients with bioprosthetic left side heart valves failure:1-year follow-up from a multi-center experience | Summary | Know More | International Journal of Cardiology (2023) | 97 Patients | Prospective, multi-centre study | 1 Year | Elisabetta Moscarella, Italy |
| OR 20 | Quantitative Angiographic Assessment of Aortic Regurgitation Following 11 TAVR Devices: An Update of a Multicenter Pooled Analysis | Summary | Know More | Journal of the Society for Cardiovascular Angiography & Interventions (2022) | 108 out of 2665 | Retrospective, multi-centre study | - | Mahmoud Abdelshafy, Ireland |
| OR 19 | Transcatheter aortic valve implantation: a report on Serbia’s first systematic program | Summary | Know More | Frontiers in Cardiovascular Medicine (2022) | 13 out of 56 Patients | Cohort study | 30 Days | Darko Boljevic, Serbia |
| OR 18 | Balloon-expandable TAVR bioprostheses: area or perimeter sizing? A prospective pilot study | Summary | Know More | Journal of Interventional Cardiology (2022) | 60 Patients | Prospective, single-centre study | 1 Year | Jonathan Halim, The Netherlands |
| OR 17 | Short-term outcome after transcatheter aortic valve replacement with a novel balloon-expandable valve | Summary | Know More | Netherlands Heart Journal (2022) | 120 Patients | Prospective, single-centre study | 6 Months | Jonathan Halim, The Netherlands |
| OR 16 | Transcatheter mitral valve-in-valve implantation with the balloon expandable Myval device | Summary | Know More | Journal of Clinical Medicine (2022) | 11 Patients | Multi-centre, retrospective study | 6 Months | Sara Blasco-Turrión, Spain |
| OR 15 | Transcatheter aortic valve implantation for severe bicuspid aortic stenosis- 2 years follow up experience from India | Summary | Know More | Frontiers in Cardiovascular Medicine (2022) | 70 BAV Patients of 287 | Multi-centre study | 2 Years | Vijay Kumar, India |
| OR 14 | Comparing two-year outcomes of balloon expandable Myval and self- expanding Evolut R in severe aortic valve stenosis | Summary | Know More | International Journal of Cardiology (2023) | 58 out of 166 Patients | Retrospective, single-center, observational, cohort analysis | 2 Years | Elisabetta Moscarella, Italy |
| OR 13 | Feasibility of precise commissural and coronary alignment with balloon-expandable TAVI | Summary | Know More | Revista Española de Cardiología (2022) | 10 Patients | Prospective study | 1 Month | Sandra Santos-Martınez, Spain |
| OR 12 | Safety and efficacy of Myval implantation in Patients with severe bicuspid aortic valve stenosis-a multi-center real world experience | Summary | Know More | Journal of Clinical Medicine (2022) | 68 Patients | Retrospective study | 30 Days | Ahmed Elkoumy, Ireland |
| OR 11 | Transfemoral transcatheter aortic valve implantation under conscious sedation (SPANISH) | - | Know More | Revista Medica Chile (2021) | 3 out of 15 Patients | Retrospective, Single-center | 30 Days | RENÉ HAMEAU D, Chile |
| OR 10 | Initial experience with a novel, modular, minimalistic approach for transfemoral aortic valve implantation | Summary | Know More | International Journal of Cardiology (2021) | 888 Patients | Retrospective | In-hospital, 30 Days | Won-Keun Kim, Germany |
| OR 09 | First experiences with a new balloon-expandable Myval transcatheter aortic valve: a preliminary study | Summary | Know More | Herz Cardiovascular Diseases (2021) | 25 Patients | Retrospective study | 3 Months | Ali Rıza Akyüz, Turkey |
| OR 08 | Myval™ versus alternative balloon-and self-expandable transcatheter heart valves: A central core lab analysis of conduction disturbances | Summary | Know More | International Journal of Cardiology (2021) | 135 out of 1131 Patients | Central corelab analysis, retrospective registry | 1 Year | Santos Martinez S, Spain |
| OR 07 | Early multicenter experience of a new balloon-expandable Myval™ transcatheter heart valve in dysfunctional stenosed right ventricular outflow tract conduits | Summary | Know More | Annals of Pediatric Cardiology (2021) | 7 Patients | Retrospective, multi-centre study | Median follow-up 16 months | Muthukumaran C Sivaprakasam, India |
| OR 06 | Next-generation balloon-expandable Myval™ transcatheter heart valve in low-risk aortic stenosis Patients | Summary | Know More | Catheterization and Cardiovascular Interventions (2021) | 100 Patients | Retrospective, multi-center registry | 30 Days | Mario Garcia-Gomez, Spain |
| OR 05 | Early clinical and haemodynamic matched comparison of balloon-expandable valves (MATCH-BALL) | Summary | Know More | Heart (2021) | 130 of 416 Patients | Prospective study | 30 Days | Jose R Delgado-Arana, Spain |
| OR 04 | Operator preference and determinants of size selection | Summary | Know More | International Journal of Cardiology (2021) | 1115 Patients | Retrospective survey | - | Hideyuki Kawashima, Ireland |
| OR 03 | Quantitative angiographic assessment of aortic regurgitation after transcatheter aortic valve implantation among three balloon-expandable valves | Summary | Know More | Global Heart (2021) | 108 out of 744 Patients | Retrospective, multi-center study | Post- implantation aortography | Hideyuki Kawashima, Ireland |
| OR 02 | Single-center experience of 105 minimalistic transfemoral transcatheter aortic valve replacement and its outcome | Summary | Know More | Indian Heart Journal (2021) | 105 Patients | Single-center, retrospective study | 30 Days | Ravinder Singh Rao, India |
| OR 01 | First-in-human evaluation of a novel balloon-expandable transcatheter heart valve in Patients with severe symptomatic native aortic stenosis: the MyVal-1 study | Summary | Know More | EuroIntervention (2020) | 30 Patients | First-in-human, prospective, multi-center, single-arm, open-label study | 1 Year | Samin K. Sharma, USA |
| Abstracts (25) | ||||||||
| AB 25 | Myocardial Work Indices Capture Early Reverse Remodeling After TAVI: A Prospective Single-Center Study | - | Know More | JACC: CARDIOVASCULAR INTERVENTIONS (2026) | - | Prospective, Single-Center Study | 30-day | Georgios E. Papadopoulos, Cyprus |
| AB 24 | Comparison of Myval Versus SAPIEN Transcatheter Heart Valves in Severe Aortic Stenosis: A Systematic Review and Meta-Analysis | - | Know More | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2025) | - | - | - | Muhammad Haris Khan, Pakistan |
| AB 23 | Comparative Outcomes of Myval Versus Contemporary Transcatheter Heart Valves: A Meta-Analysis of Randomized Controlled Trials and Propensity Score–matched studies | - | Know More | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2025) | - | - | 30-day, 1-year | Robert Alcantara, Brazil |
| AB 22 | Effectiveness of Myval Balloon-Expandable vs Evolut Self Expanding Valves for Severe Aortic Stenosis: A Systematic Review and | - | Know More | Conference Abstract | - | Systematic Review and Meta-Analysis | 30-day, 1-year | Danielle Howell, New York |
| AB 21 | Percutaneous Valve Implantation in Pulmonary Artery Branches for Severe Pulmonary Regurgitation Secondary to Native Valve Endocarditis | - | Know More | Circulation (2025) | - | - | - | Floreancia Munoz, Argentin |
| AB 20 | Comparison Of Hemodynamic Performance Between Myval and Sapien 3 Ultra Resilia- Insights From Published Data | Summary | Know More | JACC: CARDIOVASCULAR INTERVENTIONS (2025) | - | - | 30-day | Akihiro Tobe, Ireland |
| AB 19 | Comparative Outcomes of Myval versus Contemporary Transcatheter Heart Valves: A Systematic Review and Meta-Analysis | - | Know More | Journal of the Society for Cardiovascular Angiography & Interventions (2025) | 2335 patients | Systematic Review and Meta-Analysis | 30-day | Mustafa Bilal Ozbay, New jersey |
| AB 18 | Comparative Outcomes of Myval Balloon Expandable Valve Versus Evolut R/Pro Self Expanding Valves inSevere Aortic Stenosis: A Systematic Review and Meta-Analysis | Summary | Know More | Journal of the Society for Cardiovascular Angiography & Interventions -2025 | 530 of 919 patients | Systematic Review and Meta-Analysis | 30 Days | Ahmad Al Othman, Saudi Arabia |
| AB 17 | Patients With a Small Annulus in the LANDMARK Trial- Early Outcomes With Three TAVI Valves | Summary | Know More | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2025) | 125 of 245 patients | Randomized, non-inferiority trial | 30-day | Patrick Serruys, Ireland |
| AB 16 | Effectiveness and safety of myval versus self-expanding valves in patients undergoing transcatheter aortic valve implantation:a systematic review and meta-analysis | Summary | Know More | European Heart Journal (2025) | 790 of 1996 patients | Systematic review and meta-analysis | 30-day, 1-year | N. Ktenopoulos, Greece |
| AB 15 | Short- and Midterm Outcomes Following TAVR With Two Intra-Annular Transcatheter Aortic Valves | - | Know More | Structural Heart | 144 patients | single-center all-comer study | 30 Days and 1 Years | Matjaz Bunc, Slovenia |
| AB 14 | Early Outcomes With Three TAVI Valves (Myval, Sapien, and Evolut Series) in Women - Substudy of Landmark Trial | Summary | Know More | JACC: Cardiovascular Interventions (2025) | 193 of 369 (Total 768 Patients) | RCT | 30 Days | Akihiro Tobe, Ireland |
| AB 13 | “Smart” Analysis of the Landmark Trial - Early Outcomes | Summary | Know More | JACC: Cardiovascular Interventions (2025) | 125 of 245 (Total 768 Patients) | RCT | 30 Days | Patrick W. Serruys, Ireland |
| AB 12 | The Current Generation of THV: A Single-Center Propensity Score Match Analysis | Summary | Know More | JACC: Cardiovascular Interventions (2024) | 228 Patients | Single-center, propensity-score matching study | 1 Year | Matjaz Bunc, Slovenia |
| AB 11 | Initial Experience With the Myval Balloon-Expandable Transcatheter Heart Valve in Argentina | Summary | Know More | JACC: Cardiovascular Interventions (2024) | 500 Patients | Prospective multi-center registry | - | Federico Blanco Argentina |
| AB 10 | Conduction Disturbances and Permanent Pacemaker Implantation After Myval Transcatheter Heart Valve or Contemporary Standard Valves (Sapien and Evolut) | Summary | Know More | JACC: Cardiovascular Interventions (2024) | Baseline 757, Before discharge 744, After 30 days 715 (Total 768) | Prospective randomized trial | 30 Days | Pieter Smits, The Netherlands |
| AB 09 | Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial | Summary | Know More | "JACC: Cardiovascular Interventions (2024)" | 352 out of 706 Patients | Prospective randomized trial | 30 Days | Pieter Smits, The Netherlands |
| AB 08 | Comparison of the Self-Expandable Acurate Neo 2 and the New Balloon-Expandable Myval Series Transcatheter Heart Valve at 4-Year Follow-Up | Summary | Know More | "JACC: Cardiovascular Interventions (2024)" | 401 out of 545 Patients | Multicentric analysis | 4 Years | Akash Jain, Spain |
| AB 07 | Win Ratio Analysis of the LANDMARK Trial: Myval Transcatheter Heart Valve vs Contemporary Standard Valves (Sapien and Evolut) in Patients With Severe Aortic Stenosis | Summary | Know More | "JACC: Cardiovascular Interventions (2024)" | 768 Patients | "Multicenter, randomized, non-inferiority trial" | 30 Days | Akihiro Tobe, Ireland |
| AB 06 | Commissural/Coronary Alignment with the Novel Myval™ Octacor THV-The Octa Align Technique | Summary | Know More | JACC: Cardiovascular Interventions (2023) | 30 Patients | - | - | Pruthvi C. Revaiah, Ireland |
| AB 05 | Early single-center experience with Meril’s Myval transcatheter heart valve | Summary | Know More | JACC: Cardiovascular Interventions (2022) | 39 Patients | Single-centre, single-arm, open label, prospective registry | 30 Days | Alberto Colella Cervone, Brazil |
| AB 04 | Safety and efficacy of Myval™ transcatheter heart valve for treatment of severe symptomatic aortic stenosis at 30‐days | Summary | Know More | Catheterization and Cardiovascular Intervention (2020) | 7 Patients | Retrospective review | 1 Month | Nayef A. Al Asiri, Saudi Arabia |
| AB 03 | Implant of Myval transcatheter aortic valve in Patients with severe aortic stenosis | Summary | Know More | Structural Heart (2020) | 5 Patients | Prospective study | 30 days, 6 Months | Andrea Janet Robaina Barrios, Venezuela |
| AB 02 | Clinical and haemodynamic outcomes of Patients who underwent transcatheter mitral valve-in-valve replacement: one- month results | Summary | Know More | The American Journal of Cardiology (2020) | 10 Patients | - | 1 Month | Ravinder Singh Rao, India |
| AB 01 | Evaluation of balloon expandable transcatheter heart valve in the treatment of severe symptomatic native aortic stenosis: the first-in human MyVal-1 study | Summary | Know More | Structural Heart (2020) | 100 Patients | First-in-human, prospective, multi-centre, single-arm study | 1 Month | Ravinder Singh Rao, India |
| Case Reports (62) | ||||||||
| CR 62 | From Paravalvular Leak to Transvalvular Regurgitation: A Case of Persistent Symptoms Afte Transcatheter Aortic Valve Implantation Requiring Redo Transcatheter Aortic Valve Implantation | Summary | Know More | Archives of the Turkish Society of Cardiology (2026) | 1 patient | - | Post-procedur al, in-hospital | Ehsan Khalilipur, Iran |
| CR 61 | Upfront chimney stenting along transcatheter balloon- expandable aortic valve implantation: why not? | - | Know More | Journal of Cardiovascular Medicine (2026) | 1 patient | - | Post-procedur al, in-hospital | Fortunato Iacovelli, Italy |
| CR 60 | Left ventricular outflow tract obstruction due to anterior mitral valve leaflet displacement following transcatheter mitral valve replacement: Considerations for future digital planning | Summary | Know More | Cardiovascular Revascularization Medicine: Interesting Cases (2026) | 1 patient | - | Postprocedural, 2-year | Lucas Uchoa de Assis, The Netherlands |
| CR 59 | Breaking the Limits: Transcarotid Valve-in-Valve Transcatheter Aortic Valve Implantation With Bioprosthetic Valve Fracture in a Small Mitroflow and Extracorporeal Membrane Oxygenation Rescue | Summary | Know More | Interdisciplinary CardioVascular and Thoracic Surgery (2026) | 1 patient | - | Post- procedural, 3-month | Victor X. Mosquera Spain |
| CR 58 | Heterotopic Implantation of an Embolized Valve During Transcatheter Mitral Valve Replacement | Summary | Know More | Structural Heart (2026) | 1 patient | - | 1-month | Vyanne Hei-Tung Chan, China |
| CR 57 | Zero-contrast Balloon-expandable Transcatheter Aortic Valve Implantation With Embolic Protection in Pure Aortic Regurgitation | Summary | Know More | Canadian Journal of Cardiology (2026) | 1 patient | - | Post-procedur al, in-hospital | Won-Keun Kim, Germany |
| CR 56 | Surgical retrieval and repositioning of malpositioned prosthetic pulmonic valve in a patient with situs inversus dextrocardia and tetralogy of Fallot: a case report | - | Know More | International Journal of Surgery Case Reports (2026) | 1 patient | - | Post-procedur al, in-hospital | Chusak Nudaeng, Thailand |
| CR 55 | Frozen Leaflet During Transcatheter Balloon-Expandable Aortic Valve Implantation: Early Recognition and Safe Management | Summary | Know More | JACC: CASE REPORTS (2026) | 1 patient | - | Post-procedur al, in-hospital | Graziella Pompei, Italy |
| CR 54 | Transcatheter pulmonary valve implantation for re-intervention in recurrent right ventricular outflow tract obstruction | Summary | Know More | Journal of Cardiology Cases (2026) | 1 patient | - | Post procedure | Babu Ezhumalai, India |
| CR 53 | Ventricular Septal Defect and Complete Atrioventricular Block Following Transcatheter Aortic Valve Implantation: A Case Report | Summary | Know More | International Journal of the Cardiovascular Academy (2026) | 1 patient | - | 1-month | Sefa Erdi Ömür, Turkey |
| CR 52 | TAVI in a patient with severe bicuspid aortic valve stenosis in cardiogenic shock: case report | Summary | Know More | Argentinian Journal of Interventional Cardiology (2025) | 1 patient | - | 30-day, 3-month | Juan Pablo Lerner, Argentina |
| CR 51 | Hybrid valve-in-valve implantation for bioprosthetic antrioventricular valve stenosis in a failing fontan circulation: A case report | - | Know More | Progress in Pediatric Cardiology (2025) | 1 patient | - | - | Ahmed Afifi, UK |
| CR 50 | Unusual Complications after Transcatheter Aortic Valve Replacement: Gastrointestinal Bleeding in an Elderly Patient with Previous Coronary Artery Bypass Graft: A Case Report | Summary | Know More | Advanced Biomedical Research (2025) | 1 patient | - | Post procedure | Habib Haybar, Iran |
| CR 49 | Transcatheter Mitral Valve Replacement in Mitral Annular Calcification Using the Novel Myval Valve: Contribution to the Growing Worldwide Experience | Summary | Know More | ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2025) | 1 Patient | - | 1,3, and 6 Months | Teoman Kılıç, Turkey |
| CR 48 | Successful Transcatheter Aortic Valve Replacement in a Patient with Previous Aortic Coarctation Bypass Graft: A Case Report | - | Know More | Catheterization and Cardiovascular Interventions (2025) | 1 Patient | - | Post procedural | Georgios E. Papadopoulos, Greece |
| CR 47 | Burkholderia cepacia infective endocarditis of a double-layer transcatheter pulmonary valve | - | Know More | Cardiology in the Young (2025) | 1 Patient | - | PostProcedural, 3-month, 6-month and 1-year | Kenan Öztürker , Turkey |
| CR 46 | Parallel Transcatheter Valve and Stent Placement with Subsequent Stent Occlusion to Address a Giant Dysfunctional RVOT in a Patient with Repaired Tetralogy of Fallot | Summary | Know More | Pediatric Cardiology (2025) | 1 Patient | - | PostProcedural, 6-month | Eliú David Pérez Nogales, Spain |
| CR 45 | Transcatheter aortic valve implantation via the left axillary artery route in a patient with a permanent pacemaker: The first transaxillary artery route experience with a Meril’ s MyvalTM transaortic valve in Turkey | Summary | Know More | Anatolian Journal of Cardiology (2025) | 1 Patient | - | Post-procedur al | Telat Keleş, Turkey |
| CR 44 | The First Pediatric LAMPOON Procedure for TMVR (Valve-in-Ring) | Summary | Know More | VALVULAR HEART DISEASE | 1 Patient | - | postoperative, 6-month | Abdurashid Mussayev, Kazakhstan |
| CR 43 | Percutaneous Mitral Valve-in-Ring Procedure in a Case of Severe Mitral Regurgitation Repaired with a Surgical Flexible Ring: A Step-by-Step Description | Summary | Know More | ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2025) | 1 Patient | - | 3 Months | Hüseyin Bozbaş, Türkiye |
| CR 42 | Percutaneous pulmonary valve implantation with a Myval Octacor device in an adolescent patient: First Polish experience | Summary | Know More | Polish Heart Journal (2025) | 1 Patient | - | Post-procedural | Oksana Trębacz, Poland |
| CR 41 | Transcatheter valve-in-valve replacement for degenerated mitral bioprosthesis using Myval device | Summary | Know More | Turkish Journal of Thoracic and Cardiovascular Surgery (2025) | 1 Patient | - | 6 Months | Serkan Aslan, Türkiye |
| CR 40 | Unanticipated change in access site and anesthetic considerations for transcarotid transcatheter aortic valve implantation procedure: A case report | Summary | Know More | Indian J Case Reports (2025) | 1 Patient | - | 3-6 Months | Avinash Rajendran, India |
| CR 39 | Six-Year Follow-Up of TAVI In Rheumatic Severe Aortic Stenosis Using MYVAL THV: A Case Report | Summary | Know More | European Journal of Cardiovascular Medicine (2025) | 1 Patient | - | 3 Months, 1, 2 and 6 Year | Dr. Rajendra Kumar Jain, India |
| CR 38 | Redo-Transcatheter Aortic Valve Replacement for Migration of Myval Transcatheter Heart Valve in Pure Aortic Regurgitation | Summary | Know More | JACC: (2025) | 1 Patient | - | 1 Month | Emmanuel Gal, France |
| CR 37 | When surgery is not an option: case report of transcatheter valve-in-valve replacement for mitral valve dysfunction | Summary | Know More | The Egyptian Heart Journal (2025) | 1 Patient | - | 2-Year | Yakup Alsancak, Turkey |
| CR 36 | Transcatheter tricuspid valve-in-valve implantation in a paediatric patient: a case report | Summary | Know More | Cardiology in the Young (2025) | 1 Patient | - | Post-operative , 17 months | Musa Öztürk, Turkey |
| CR 35 | A challenging TAVI-in-TAVI with Balloon expandable | Summary | Know More | The Journal of Heart Valve Disease (2025) | 1 Patient | - | Dr. Dibya Ranjan Behera | |
| CR 34 | Transcatheter Aortic Valve Replacement in Pure Native | Summary | Know More | Catheterization and Cardiovascular Interventions (2025) | 1 Patient | - | 30 Days | Jayesh Bhaskaran, India |
| CR 33 | Reflections on transfemoral TAVI in dextrocardia with severe aortic regurgitation: Navigating anatomical complexity, off-label innovation, and future directions | Summary | Know More | International Journal of Cardiology Congenital Heart Disease (2025) | 1 Patient | - | 30 Days | Pandula Athauda arachchi, Sri Lanka |
| CR 32 | First Transcatheter Valve-in-Valve Implantation With Myval Octacor Into a Failed Biological Prosthetic Aortic Valve in Serbia | Summary | Know More | Cardiology Research (2025) | 1 Patient | - | 6 Months | Valentina Balint Jovanovic, Serbia |
| CR 31 | Successful Management of Myval Transcatheter Heart Valve Embolization into Abdominal Aortic Aneurysm During Transcatheter Aortic Valve Replacement | Summary | Know More | The Texas Heart Institute Journal (2024) | 1 Patient | - | 3 Months | Artemio García-Escobar, Spain |
| CR 30 | Single-stage transcatheter mitral valve in valve implantation and paravalvular leak closure following failure of bioprosthetic valve and cardiogenic shock | Summary | Know More | IHJ Cardiovascular Reports (2024) | 1 Patient | - | Post-procedural | Dhamodaran Kaliyamoorthy India |
| CR 29 | Transcatheter Mitral Valve-in-valve Implantation with | Summary | Know More | Indian Journal of Clinical Cardiology (2024) | 1 Patient | - | Post-procedural | Suresh Kumar Paidi India |
| CR 28 | Transcatheter aortic valve implantation using balloon-expandable Myval transcatheter heart valve in a patient with bicuspid aortic valve with low-flow , low-gradient | Summary | Know More | Nepalese Heart Journal (2024) | 1 Patient | - | Post-procedural | Chandra Mani Adhikari Nepal |
| CR 27 | Transcarotid aortic valve implantation using the novel | Summary | Know More | Polish Heart Journal (2024) | 1 Patient | - | Post procedural | Robert Sobczyński, Poland |
| CR 26 | Coronary Artery Protection with Chimney Stent in High-Risk Case of Coronary Occlusion in Transcatheter Aortic Valve Implantation | Summary | Know More | Journal of National Heart & Lung Society Nepal (2024) | 1 Patient | - | Post procedural | Chandra Mani Adhikari, Nepal |
| CR 25 | Transcatheter pulmonary valve implantation with custom-made 35-mm Myval™ transcatheter heart valve | Summary | Know More | Annals of Pediatric Cardiology (2024) | 1 Patient | - | Post procedural | Sivasubramanian Ramakrishnan, India |
| CR 24 | Coronary alignment by OctaAlign technique using | Summary | Know More | Journal of Cardiovascular Intervention (2024) | 1 Patient | - | Post procedural | Raja Ramesh Nukavarapu, India |
| CR 23 | Direct aortic TAVI via anterior right mini thoracotomy using 32 mm myval for pure aortic regurgitation | Summary | Know More | Journal of Cardiothoracic Surgery (2024) | 1 Patient | Post procedural | Firas Aljanadi,UK | |
| CR 22 | Technical Aspects for Transcatheter Aortic Valve Replacement with the Novel Balloon-Expandable Myval Octacor | Summary | Know More | JACC: Cardiovascular Intervention (2024) | 1 Patient | - | Post-procedural | Alfonso Ielasi, Italy |
| CR 21 | Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up | Summary | Know More | Frontiers in Cardiovascular Medicine (2023) | 5 Patients | - | 1 Year | Abdurashi d Mussayev, Kazakhstan |
| CR 20 | Transcatheter aortic valve implantation for aortic regurgitation in HeartMate II supported patient using Myval THV: a case report | Summary | Know More | Oxford Medical Case Reports (2023) | 1 Patient | - | 1 Year | Mohamad Hamieh, Lebanon |
| CR 19 | Case report: A complex case of valve-in-valve TAVI and left bundle branch pacing for severe aortic regurgitation with partially corrected type A aortic dissection and low ejection fraction | Summary | Know More | Frontiers in Cardiovascular Medicine (2023) | 1 Patient | - | 1 Year | Peter Marko Mihailovič, Slovenia |
| CR 18 | Pulmonary valve replacement in a large and tortuous right ventricle outflow tract with a 32 mm Myval valve under local anesthesia: challenges and technical considerations: a case report | Summary | Know More | European Heart Journal Case Reports (2023) | 1 Patient | - | 3 Months | Ali Houeijeh, France |
| CR 17 | Case report: a novel surgical technique for rapid valve-in-ring implantation into the native aortic annulus during left ventricular assist device implantation | Summary | Know More | Frontiers in Cardiovascular Medicine (2023) | 1 Patient | - | 6 Months | Yuriy Pya, Kazakhstan |
| CR 16 | Left ventricular assist device implantation combined with direct transaortic transcatheter valve-in-annular stent implantation after rescue mechanical Bentall procedure, a case report | Summary | Know More | BMC Journal of Cardiothoracic Surgery (2023) | 1 Patient | - | Post-procedural | Yuriy Pya, Kazakhstan |
| CR 15 | In-series transcatheter aortic valve replacement-in-transcatheter aortic valve replacement: ACURATE neo transcatheter heart valve degeneration successfully managed with Myval, avoiding coronary flow obstruction-a case report | Summary | Know More | Structural Heart (2023) | 1 Patient | - | 1 Month | Joao Felipe Barros de Toledo, Brazil |
| CR 14 | Redo-transcatheter aortic valve implantation in a patient at high risk of coronary obstruction due to sinus sequestration | Summary | Know More | European Heart Journal (2023) | 1 Patient | - | Post-procedural | Ying-Hwa Chen, Taiwan |
| CR 13 | Under-deployed TAVI with occluded left-main and severe aortic regurgitation; bailout chimney-in-chimney stenting and aggressive post-dilatation saves the day | Summary | Know More | Clinical Case Reports (2022) | 1 Patient | - | 1 Week | Pandula Athauda-arachchi, Sri Lanka |
| CR 12 | Transcatheter mitral valve-in-valve replacement transeptally using a novel balloon-expandable device | Summary | Know More | Journal of Cardiac Surgery (2022) | 1 Patient | - | Procedural Details | Maria Drakopoulou, Greece |
| CR 11 | Transcatheter treatment tricuspid regurgitation by valve-in-ring implantation with a novel balloon-expandable Myval™ THV | Summary | Know More | Clinical vignette Kardiologia Polska (2022) | 1 Patient | - | Procedural Details | Hüseyin Ayhan, Turkey |
| CR 10 | Pulmonary percutaneous valve implantation in large native right ventricular outflow tract with 32mm Myval transcatheter heart valve | Summary | Know More | Catheterization and Cardiovascular Interventions (2021) | 1 Patient | - | 1 Year | Alejandro Rodríguez Ogando, Spain |
| CR 09 | Transcatheter aortic valve implantation for aortic insuffiency in Patients with left ventricular assistance | Summary | Know More | Giornale Italiano di Cardiologia (2021) | 1 Patient | - | Post-procedural | Marco B. Ancona, Milan, Italy |
| CR 08 | First-in-man valve-in-valve with the new balloon-expandable Myval™ transcatheter heart valve in a failed sutureless perceval bioprosthesis | Summary | Know More | Journal of Cardiac Surgery (2021) | 1 Patient | - | 30 Days | Igor Belluschi, Italy |
| CR 07 | Transcatheter tricuspid valve-in-valve implantation with a novel balloon expandable Myval THV | Summary | Know More | The Annals of Thoracic Surgery (2021) | 1 Patient | - | 1 Month | Bilge Duran Karaduman, Turkey |
| CR 06 | Tip-to-base lampoon to prevent left ventricular outflow tract obstruction in a valve-in-ring transcatheter mitral valve replacement: first LAMPOON procedure in turkey and first LAMPOON case for transseptal Myval™ implantation | Summary | Know More | Anatolian Journal of Cardiology (2021) | 1 Patient | - | 1 Month | Teoman Kılıç, Turkey |
| CR 05 | ROTAVI: Simultaneous left main rotablation and transcutaneous aortic valve implantation in calcified coronaries and severe aortic stenosis a case report | Summary | Know More | European Heart Journal (2020) | 1 Patient | - | Postprocedural | Himanshu Gupta, India |
| CR 04 | Successful management of left main coronary artery obstruction following transcatheter aortic valve implantation | Summary | Know More | IHJ Cardiovascular Case Reports (2020) | 1 Patient | - | Procedural Details | Viveka Kumar, India |
| CR 03 | Myval™ and mini-chimney stenting to prevent coronary obstruction during full root stent-less aortic valve-in-valve procedure | Summary | Know More | Cardiovascular Revascularization Medicine (2020) | 1 Patient | - | 6 Months | Alfonso Ielasi, Italy |
| CR 02 | First transcatheter pulmonary valve implantation-an Indian made valve | Summary | Know More | IHJ Cardiovascular Case Reports (2020) | 1 Patient | - | 6 Months | Muthukumaran Chinnasamy Sivaprakasam, India |
| CR 01 | Successful transcatheter aortic valve replacement in a kidney allograft patient on rapamycin | Summary | Know More | Indian Journal of Transplantation (2019) | 1 Patient | - | Procedural Details | Aashish Chopra, India |
| Case Series (15) | ||||||||
| CS 15 | Early Experience With Septal Scoring Along the Midline Endocardium in the Asia-Pacific Region | Summary | Know More | JACC: Case Reports (2026) | 1 of 4 patients | - | 3-month | Ka-Chun Un, China |
| CS 14 | The hybrid cable technique in transcatheter mitral valve implantation with Myval THV—Technical insights from three high-risk cases | Summary | Know More | Frontiers in Cardiovascular Medicine (2026) | 3 patients | - | Postprocedural | Giuseppe Nasso, Italy |
| CS 13 | Transcatheter Aortic Valve Replacement for Aortic Regurgitation: A Case-Based Review | Summary | Know More | The American Journal of Cardiology (2026) | 1 of 3 patients | - | Postprocedure, 1-month | Lucas Uchoa de Assis, The Netherlands |
| CS 12 | Experience with percutaneous pulmonary valve implantation at a leading cardiovascular hospital in Colombia. Case series | Summary | Know More | Archivos de Cardiología de México (2025) | 1 of 10 patients | - | - | Diego A, Colombia |
| CS 11 | Transcatheter Valve-In-Valve Implantation in Patients With Fluoroscopically Invisible Tricuspid Valve Prostheses | Summary | Know More | Journal of American College of Cardiology, 2025 | 3 Patients | - | Post- procedure | Dzhem Farandzha, Bulgaria |
| CS 10 | Prosthetic Heart Valve Interactions and Their Clinical Significance During Transcatheter Left-Sided Double Valve Replacement | Summary | Know More | Journal of American College of Cardiology (2025) | 3 Patients | - | - | Dr Vasu Nandhakumar, India |
| CS 09 | Prediction of Prosthetic Heart Valve Interaction During Transcatheter Double-Valve Replacement Using a Bench Model | Summary | Know More | Journal of American College of Cardiology (2025) | 3 Patients | - | - | Dr Vasu Nandhakumar, India |
| CS 08 | Transcatheter aortic valve replacement in patients with a pre-existing prosthetic mitral valve: a single center | Summary | Know More | The Egyptian Heart Journal (2024) | 2 Patients | - | - | Oyewole A. Kushimo, Nigeria |
| CS 07 | A new simple technique for stabilizing the guidewire position within the left ventricle during transcatheter mitral valve‐in‐valve implantation | Summary | Know More | Catheterization and Cardiovascular Interventions (2024) | 2 Patients | - | Post-procedure | Kothandam Sivakumar, India |
| CS 06 | Transcatheter Aortic Valve Implantation in Two High-Risk Patients with Low Coronary Ostial Heights Using the Novel Balloon Expandable MyvalTM Valve | Summary | Know More | Journal of Cardiology And Cardiovascular Medicine (2023) | 2 Patients | - | 1 Month | Raja Ramesh N, India |
| CS 05 | Transcatheter mitral valve replacement (TMVR) for degenerated mitral valve bioprosthesis-A case series | Summary | Know More | IHJ Cardiovascular Case Reports (2023) | 5 Patients | - | 1 Month | Viveka Kumar, India |
| CS 04 | TAVR in a large bicuspid anatomy using the XL-Myval™ 32mm | Summary | Know More | Frontiers in Cardiovascular Medicine (2022) | 3 Patient | - | 30 Days | Ahmed Elkoumy, Ireland |
| CS 03 | Two case reports of transcatheter valve-in-valve implantation of Sapien 3 and MyVal in degenerated biological tricuspid prosthesis valves | Summary | Know More | European Heart Journal (2022) | 2 Patients | - | 6 Years | Rebekka Vibjerg Jensen, Denmark |
| CS 02 | First experiences with Myval™ transcatheter heart valve system in the treatment of severe pulmonary regurgitation in native right ventricular outflow tract and conduit dysfunction | Summary | Know More | Cardiology in the Young (2021) | 9 Patients | - | 9.8 months mean follow up | Ender Odemis, Turkey |
| CS 01 | Trans-catheter valve-in-valve implantation with a novel balloon expandable device in Patients with bioprosthetic heart valve failure: A case series. | Summary | Know More | Cardiovascular Revascularization Medicine (2020) | 5 Patients | - | Postprocedural (Upto 72 hrs) | Alfonso Ielasi, Italy |
| Editorial/ Editorial Letters (18) | ||||||||
| EL 18 | The emerging story of Myval transcatheter heart valve: lessons from the LANDMARK trial | - | Know More | European Heart Journal - Cardiovascular Imaging (2026) | - | - | - | Paolo Springhetti, Canada |
| EL 17 | LANDMARK Device or More of the Same? | - | Know More | Journal of the American College of Cardiology (2026) | - | - | - | Ron Waksman, USA |
| EL 16 | Transcarotid transcatheter aortic valve implantation in selected patients | Summary | Know More | Polish Heart Journal (2025) | - | - | - | Mesut Engin, Turkey |
| EL 15 | Myval Octacor: Innovative Design, Early Hemodynamic Gains, and Future Outlook | - | Know More | Catheterization and Cardiovascular Interventions (2025) | - | - | - | Ashish H. Shah, Canada |
| EL 14 | Myval, Pulmonary and Cardiac Rehabilitation, Pulmonary Embolism… | Summary | Know More | THE ANATOLIAN JOURNAL OF CARDIOLOGY (2025) | - | - | - | Çetin Erol, Turkey |
| EL 13 | The new balloon-expandable MyVal transcatheter heart valve: only good news? | Summary | Know More | Euro Intervention (2025) | - | - | Up to 10 years | Philippe Pibarot, Laval |
| EL 12 | Myval transcatheter heart valve system: a new TAVI contender and remaining uncertainties | - | Know More | EuroIntervention (2025) | 768 patients | - | 30 Days | Stephan Windecker, Freiburgstrasse |
| EL 11 | Win ratio analysis of the LANDMARK trial | Summary | Know More | American Heart Journal (2025) | 768 patients | Multi-center, randomized, open-label, non-inferiority trial | 30 Days (10 Year follow-up) | Akihiro Tobe, Ireland |
| EL 10 | Glimpse Into the Hemodynamic Performance of Myval Series vs Sapien | Summary | Know More | Structural Heart (2024) | - | - | - | Akihiro Tobe, Ireland |
| EL 09 | BASELINE trial: update in study design | Summary | Know More | American Heart Journal (2024) | - | Protocol update | - | Rutger-Jan Nuis, The Netherlands |
| EL 08 | Novel 35-mm Balloon-Expandable Transcatheter Aortic Valve Replacement | Summary | Know More | JACC: Cardiovascular Interventions (2024) | - | - | - | John Jose, India |
| EL 07 | LANDMARK trial: Update in study protocol | Summary | Know More | American Heart Journal (2024) | - | - | - | Akihiro Tobe, Ireland |
| EL 06 | Transcatheter aortic valve replacement for noncalcified aortic regurgitation. Where are we now? | Summary | Know More | REC: Inteventional Cardiology (2024) | - | - | - | Ignacio J. Amat Santos, Spain |
| EL 05 | Bicuspid aortic valve: one of the last remaining challenges for the percutaneous treatment of aortic valve disease | Summary | Know More | Revista Española de Cardiología (2023) | - | - | - | Pilar Jimenez Quevedo, Spain |
| EL 04 | Neocommissural/ Coronary Alignment with a Novel Balloon Expandable Transcatheter Aortic Valve First-in-Human Experience | Summary | Know More | JACC: Cardiovascular Interventions (2023) | 32 Patients | - | - | Pruthvi C.Revaiah, Ireland |
| EL 03 | Transcarotid transcatheter aortic valve implantation with a novel balloon expandable Myval™ THV under the local anesthesia | Summary | Know More | Journal of Geriatric Cardiology (2022) | 1 Patient | - | - | Hüseyin Ayhan, Turkey |
| EL 02 | Transcatheter Pulmonary Valve Replacement With 32-mm Balloon-Expandable Prosthesis: Another Strategy in Mildly Dilated RVOT | Summary | Know More | JACC: Cardiovascular Interventions (2021) | - | - | - | Marco B. Ancona, Italy |
| EL 01 | (Intermediate) size matters | Summary | Know More | International Journal of Cardiology (2021) | 1 Patient | - | - | Won-Keun Kim, Germany |
| Case Images (2) | ||||||||
| CI 02 | Transcatheter Aortic Valve in Failing Mechanical Aortic Valve | Summary | Know More | JACC: Cardiovascular Interventions (2024) | 1 Patient | - | - | Mario García Gómez, Spain |
| CI 01 | The novel balloon-expandable Myval transcatheter heart valve: systematic review of aortic, mitral, tricuspid | Summary | Know More | Canadian Journal of Cardiology (2024) | 1 Patient | - | - | Mariano Pellicano, Italy |
| Systematic Review (7) | ||||||||
| SR 07 | Comparative outcomes of Myval versus contemporary transcatheter heart valves: a systematic review and meta‑analysis | - | Know More | Cardiovascular Intervention and Therapeutics (2025) | 2335 Patients | - | 30 Days | Mustafa Bilal Ozbay, USA |
| SR 06 | Comparative Outcomes of Myval Balloon Expandable Valve Versus Evolut R/Pro Self Expanding Valves in Severe Aortic Stenosis: A Systematic Review and Meta-Analysis | Summary | Know More | Journal of the Society for Cardiovascular Angiography & Interventions (2025) | 919 patients | - | 30 Days | Ahmad Al Othman, Saudi Arabia |
| SR 05 | Myval versus Contemporary Valves in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis | Summary | Know More | THE ANATOLIAN JOURNAL OF CARDIOLOGY (2025) | 2084 patients from 6 studies | - | 30 days | Zeeshan Mansuri, India |
| SR 04 | Early Outcomes of Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis With Myval Versus Edwards Sapien 3 Valve: A Systematic Review and Meta-Analysis | Summary | Know More | Cureus, 2025 | 1973 patients from 4 studies | - | 30 days | Dinkar Bhasin, India |
| SR 03 | Effectiveness and Safety of Myval Versus Other Transcatheter Valves in Patients Undergoing TAVI: A Meta‐Analysis | Summary | Know More | Catheterization and Cardiovascular Interventions (2025) | Seven studies involving 3106 patients | - | 12 months | Anastasios Apostolos, Greece |
| SR 02 | A systematic review and meta-analysis of the hemodynamics and outcomes of the Myval balloon-expandable valve in patients with severe aortic stenosis and with aortic regurgitation | Summary | Know More | IJC Heart & Vasculature (2025) | 2,864 patients from 29 studies | - | 2 Years | Elfatih A. Hasabo |
| SR 01 | The novel balloon-expandable Myval transcatheter heart valve: systematic review of aortic, mitral, tricuspid and pulmonary indications | Summary | Know More | Revista Española de Cardiología (2024) | 74 Patients | - | - | Mario Garcia Gomez, Spain |
| Review Articles (15) | ||||||||
| RA 15 | A Narrative Review of the Evidence for Transcatheter Aortic Valve Implants | Summary | Know More | Journal of Cardiovascular Development and Disease (2025) | - | - | - | Leonard Lee, Australia |
| RA 14 | Contemporary Transcatheter Heart Valves for TAVI in Bicuspid Aortic Anatomy | Summary | Know More | Journal of Clinical Medicine (2025) | - | - | - | Chrysavgi Simopoulou, France |
| RA 13 | Transcatheter Aortic Valve Replacement for Aortic Insufficiency | Summary | Know More | INTERVENTIONAL CARDIOLOGY: REVIEWS, RESEARCH, RESOURCES (2025) | - | - | - | Marwan Amara, Israel |
| RA 12 | Transcatheter Aortic Valve Implantation in Large and Extra-Large Aortic Annuli: Contemporary Evidence and Performance of Third-Generation Devices | Summary | Know More | Heart And Blood Vessels (2025) | - | - | - | Igor Ivanov, Serbia |
| RA 11 | Myval transcatheter aortic valve series: An innovation in transcatheter aortic valve implantation technology | Summary | Know More | Interventional Cardiology (2024) | - | - | - | Teoman Kilic, Turkey |
| RA 10 | Transcatheter Heart Valves—An Update on Types of Valves Available, Hardware Characteristics, and Patient Selection: An Indian Perspective | Summary | Know More | Indian Journal of Clinical Cardiology (2024) | - | - | - | Anoop Agrawal, India |
| RA 09 | Pediatric cardiac interventions: Innovations from India | Summary | Know More | Annals of Pediatric Cardiology (2024) | - | - | - | Mantoo Mohsin Raj, India |
| RA 08 | Myval Transcatheter Heart Valve: The Future of Transcatheter Valve | Summary | Know More | Journal of Clinical Medicine (2024) | - | - | - | Teoman Kilic, Turkey |
| RA 07 | A novel balloon-expandable transcatheter aortic valve bioprosthesis: Myval and Myval Octacor | Summary | Know More | Expert Review of Cardiovascular Therapy (2024) | - | - | - | Carolina Montonati,Italy |
| RA 06 | Myval: a novel transcatheter heart valve for the treatment of severe aortic stenosis | Summary | Know More | Interventional Cardiology Review, Research, Resources (2023) | - | - | - | Ashok Seth, India |
| RA 05 | Prosthesis tailoring for Patients undergoing transcatheter aortic valve implantation | Summary | Know More | Journal of Clinical Medicine (2023) | - | - | - | Pier Pasquale Leone, USA |
| RA 04 | An update on new generation transcatheter aortic valves and delivery systems | Summary | Know More | Journal of Clinical Medicine (2022) | - | - | - | Gloria Santangelo, Italy |
| RA 03 | Choice of transcatheter heart valve: should we select the device according to each patient’s characteristics or should it be “one valve fits all”? | Summary | Know More | Annals of Translational Medicine (2020) | - | - | - | Matthias Renker, Germany |
| RA 02 | Myval transcatheter heart valve system in the treatment of severe symptomatic aortic stenosis | Summary | Know More | Future Cardiology (2020) | - | - | - | Samin K Sharma, USA |
| RA 01 | Current status of transcatheter aortic valve replacement in India | Summary | Know More | Cardiovascular Diagnosis and Therapy (2019) | - | - | - | Puneet Gupta, India |
| Scientific Letter (2) | ||||||||
| SL 02 | First experiences with the balloon-expandable Myval® transcatheter aortic valve from Turkey | Summary | Know More | Anatolian Journal of Cardiology (2020) | - | - | - | Uğur Arslan, Turkey |
| SL 01 | Balloon-expandable Myval transcatheter aortic valve implantation. First experience in Spain | Summary | Know More | Revista Espanola de Cardiologia (2020) | - | - | - | Sandra Santos-Martınez, Spain |
| Scientific Report (2) | ||||||||
| SCR 02 | Bench evaluation of MyVal OCTACOR THVs at expansion limits for paediatric and valve-in-valve applications | - | Know More | Cardiology in the Young (2025) | - | - | - | Raymond N. Haddad, France |
| SCR 01 | Angulation and curvature of aortic landing zone affect implantation depth in transcatheter aortic valve implantation | Summary | Know More | Scientific Reports: Nature (2024) | 202 Patients out of 784 | Observational, retrospective and single-center registry | - | Riccardo Gorla, Italy |
| Study Protocols (3) | ||||||||
| SP 03 | LANDMARK trial: Update in statistical analytical plan and protocol for the one-year report | Summary | Know More | American Heart Journal (2025) | - | Prospective, randomized, multi-national, multi-centre, open-label, non-inferiority tria | Protocol update | Akihiro Tobe, Ireland |
| SP 02 | Randomized comparison of TAVI valves: The Compare-TAVI trial | Summary | Know More | American Heart Journal (2024) | - | RCT | - | Christian Juhl Terkelsen, Denmark |
| SP 01 | Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in Patients with severe symptomatic aortic valve stenosis: The LANDMARK trial | Summary | Know More | American Heart Journal (2021) | - | Prospective, randomized, multi-national, multi-centre, open-label, non-inferiority trial | - | Hideyuki Kawashima, Ireland |
| Comment (3) | ||||||||
| C 03 | Head-to-head comparison of balloon-expandable transcatheter heart | Summary | Know More | THE LANCET (2025) | 514 out of 1031 Patients | Multicentre, all-comers, randomised, non-inferiority trial | 1 Year | Mariama Akodad France |
| C 02 | Myval Balloon-Expandable Prosthesis in Argentina: Time to Take the Bull by the Horns | Summary | Know More | Revista Argentina de Cardioangiología Intervencionista (2024) | 300 Patients | Prospective multi-center registry | Post-procedure | Federico Blanco, Argentina |
| C 01 | New-generation Myval transcatheter heart valve in severe aortic stenosis | Summary | Know More | THE LANCET (2024) | 384 Patients | RCT | 30 Days | Mariama Akodad, France |
| Short Communication (1) | ||||||||
| SC 01 | Four-year follow-up after prophylactic awake peripheral veno-arterial ECMO during transcatheter aortic valve replacement | Summary | Know More | Advances in Interventional Cardiology (2025) | 590 patients | Randomized trials | 4-Year | Linar Faizov, Kazakhstan |
| BioMime™ Sirolimus Eluting Coronary Stent System-Clinical Publications (Total = 46 articles) | ||||||||
| Original Research Articles (12) | ||||||||
| OR 12 | Clinical and angiographic outcomes of ultrathin Biomime versus thicker ultimate stents during primary percutaneous coronary interventions | Summary | Know More | Romanian Journal of Cardiology | 370 | Prospective, single-center, randomized, open-label, active-controlled, noninferiority trial | 1 year | Magdy Algowhary |
| OR 11 | Safety and Efficacy of BioMime Sirolimus-eluting Stent System in | Summary | Know More | Cardiology Research Journal (2024) | 771 Patients | Post-marketing, multicenter, single-arm, observational clinical registry | 2 Years | Martin Hudec, Slovakia |
| OR 10 | Real-world evidence of BioMime sirolimus-eluting stent in obstructive | Summary | Know More | AsiaIntervention (2024) | 250 Patients | Prospective, single-arm, multicentre study | 5 Years | Upendra Kaul, India |
| OR 09 | Long-Term Assessment of Thin-Strut BioMime Coronary Stent System in | Summary | Know More | Cardiology Research (2023) | 1188 patients | Retrospective, observational, single-center, post- marketing clinical follow-up study | 4 years | Girish Meennahalli Palleda, India |
| OR 08 | A Randomized Controlled Trial Comparing BioMime SirolimusEluting Stent with Everolimus-Eluting Stent: Two-Year Outcomes of the meriT-V Trial | Summary | Know More | Cardiology Research (2023) | 252 out of 256 Patients | Prospective, multi-center, randomized, active-controlled , non-inferiority trial | 2 Years | Alexandre Abizaid, Brazil |
| OR 07 | Clinical follow-up of long non-tapered sirolimus-eluting coronary stent in | Summary | Know More | REC Interventional Cardiology (2022) | 696 Patients | Prospective, nonrandomized, multi-centre study | 1 Year | Enric Domingo Ribas, Spain |
| OR 06 | Clinical outcomes of biodegradable polymer sirolimus-eluting stent in | Summary | Know More | EC Cardiology (2020) | 73 Patients | Retrospective, single-center , nonrandomized and observational study | Mean follow-up: 1.68±0.58 years | Binu Thankappan Gomathy, India |
| OR 05 | Single long stents versus overlapping multiple stents in the | Summary | Know More | The Journal of Tehran University Heart Center (2019) | 124 out of 1709 Patients | Historical cohort study | 1 Year | Alireza Amirzadegan, Iran |
| OR 04 | Randomized comparison of biodegradable polymer ultra-thin | Summary | Know More | EuroIntervention (2018) | 256 Patients | Prospective, multicentre, randomized, open-label, activecontrolled, and non-inferiority trial | 9 Months | Alexandre Abizaid, Brazil |
| OR 03 | One-year outcomes of a BioMime sirolimus-eluting coronary stent system | Summary | Know More | Indian Heart Journal (2016) | 1161 Patients | Retrospective, multi-centre study | 1 Year | Rajendra Kumar Jain, India |
| OR 02 | Late angiographic and clinical outcomes of the novel BioMime | Summary | Know More | AsiaIntervention (2016) | 250 Patients | Prospective, non randomized, single-arm, multicentre, phase II clinical study | 1 Year | Ashok Seth, India |
| OR 01 | First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vesselsresults from the meriT-1 trial | Summary | - | EuroIntervention (2013) | 30 Patients | Prospective, non-randomized, single-arm, single-centre, first-in-human study | 1 Year | Sameer Dani, India |
| Meta Analysis (2) | ||||||||
| MA 02 | Long-term follow-up after ultrathin vs. conventional 2ndgeneration drugeluting stents: a systematic review and meta-analysis of randomized controlled trials | Summary | Know More | European Heart Journal (2021) | 170 out of 20,701 Patients | Meta-analysis of 16 trials that randomized 20,701 patients | Mean follow-up: 2.5 Years | Mahesh V. Madhavan, USA |
| MA 01 | Newer generation ultra-thin strut drug- eluting stents versus older | Summary | Know More | Circulation (2018) | 170 out of 11,658 Patients | 170 out of 11,658 Patients | 1 Year | Sripal Bangalore, USA |
| Abstracts (16) | ||||||||
| AB 16 | Strut coverage of the ultrathin BioMime stent: a single-centre | Summary | Know More | EuroIntervention (2020) | 28 out of 111 Patients | Prospective, post-marketi ng OCT analysis | 3 Months | Sudipta Chattopadhyay, United Kingdom |
| AB 15 | Primary efficacy and safety outcomesof a sirolimus-eluting thin-strut | Summary | Know More | EuroIntervention (2020) | 752 Patients | Prospective, non-randomized, multi-center, open-label, observationa l registry | 9 Months | Ian Menown, United Kingdom |
| AB 14 | Safety and efficacy of sirolimuseluting stent system in all-comers realworld population with coronary artery stenosis: the MILES-GLOBAL study | Summary | Know More | EuroIntervention (2020) | 520 Patients | Multi-center, prospective, single-arm, open-label study | 1 Year | Martin Hudec, Slovakia |
| AB 13 | Safety and performance of the biodegradable polymer-coated ultrathin | Summary | Know More | EuroIntervention (2020) | 216 Patients | Retrospective, single-centre study | 2 Years | Vivek Jindal, India |
| AB 12 | Clinical outcomes from real-world patients treated with | Summary | Know More | EuroIntervention (2020) | 1003 Patients | Retrospective, single- centre study | 2 Years | Vishal Batra, India |
| AB 11 | One-year clinical outcomes in patients implanted with biodegradable | Summary | Know More | Journal of the American College of Cardiology (2019) | 216 Patients | Retrospective single-center study | 1 Year | Mohit Gupta, India |
| AB 10 | Safety and efficacy of sirolimus-eluting stent system in all-comers real-world population with coronary artery stenosis: the MILES-GLOBAL study | Summary | Know More | Journal of the American College of Cardiology (2019) | 520 Patients | Multi-centre, prospective, single-arm, open-label study | 1 Year | Martin Hudec, Slovakia |
| AB 09 | Twelve-months clinical outcomes comparing biodegradable polymer | Summary | Know More | Journal of the American College of Cardiology (2018) | 170 out of 256 Patients | Prospective, multicentre, randomized, active controlled, noninferiority clinical trial | 1 Year | Alexandre Abizaid, Brazil |
| AB 08 | Single long stent vs. overlapping multiple stents in the management of | Summary | Know More | EuroIntervention (2018) | 124 out of 1709 Patients | Historical cohort study | Mean follow-up: 441 ± 361 Days | A. Amirzadega, Iran |
| AB 07 | Efficacy and safety of an ultrathin strut sirolimus eluting stent with | Summary | Know More | European Heart Journal Supplement (2018) | 588 Patients | Prospective, non-randomized, multi- centre, open label, observational registry | 9 Months | Ian Menown, United Kingdom |
| AB 06 | Three-year clinical outcomes of BioMime sirolimus-eluting coronary | Summary | Know More | Journal of the American College of Cardiology (2017) | 250 Patients | Prospective, multi-center study | 3 Years | Ashok Seth, India |
| AB 05 | How to make a deal with distal left main coronary artery type A trifurcation lesion | Summary | Know More | Journal of the American College of Cardiology (2017) | 1 Patient | Case study | Procedural Details | Yusra Pintaningrum , Indonesia |
| AB 04 | Efficacy of the novel BioMime sirolimus-eluting stents with a | Summary | Know More | Journal of the American College of Cardiology (2013) | 280 Patients | An angiographic sub-analysis of combined meriT-1 and meriT-2 prospective clinical trials | Angiographic analysis at 8 months of both studies | Ricardo A. Costa, Brazil |
| AB 03 | First-in-human evaluation of a novel sirolimus-eluting stent with a | Summary | Know More | Journal of the American College of Cardiology (2012) | 30 Patients | Prospective, nonrandomized, single-arm, single-center study | 8-month angiographic and 1-year clinical follow- up | Erlon de Abreu Silva, Brazil |
| AB 02 | Impact of the new BioMime sirolimus-eluting stent in complex patients of daily practice-preliminary results of the meriT-2 study | Summary | Know More | Journal of the American College of Cardiology (2012) | 242 Patients | Prospective, nonrandomized, multi-center study | 8 months angiographic and 1-year clinical follow- up | Erlon de Abreu Silva, Brazil |
| AB 01 | Moving towards biomimicrydevelopment of novel BioMime sirolimus eluting coronary stent system | Summary | Know More | The American Journal of Cardiology (2011) | 250 Patients | Single-arm, multi-center trial | 1-month clinical outcome and 8-month angiographic outcomes | Ashok Seth, India |
| Review Article (5) | ||||||||
| RA 05 | Ultrathin struts drug-eluting stents: a state-of-the-art review | Summary | Know More | Journal of Personalized Medicine (2022) | - | - | - | Attilio Leone, Belgium |
| RA 04 | Novel bioabsorbable polymer and polymer-free metallic drugeluting stents | Summary | Know More | Journal of Cardiology (2018) | - | - | - | Jason Nogic, Australia |
| RA 03 | Innovative DES technologies from Meril | Summary | Know More | Minerva Cardioangiologica (2015) | - | - | - | Sanjeev Bhatt, India |
| RA 02 | Advantages of novel BioMime sirolimus eluting coronary stent system. Moving towards biomimicry | Summary | Know More | Minerva Cardioangiologica (2012) | - | - | - | Upendra Kaul, India |
| RA 01 | Moving towards Biomimicry-the development of the novel BioMime sirolimus-eluting coronary stent system | Summary | Know More | European Cardiology Review (2010) | - | - | - | Ashok Seth, India |
| Case Reports (8) | ||||||||
| CR 08 | Cuspal dissection of aorta during percutaneous coronary intervention | Summary | Know More | IHJ Cardiovascular Case Reports (2018) | 1 Patient | - | Post-procedural | Shilpa Jayaprakash, India |
| CR 07 | Bifurcation stenting. It’s easy. That’s what I thought | Summary | Know More | Journal of the American College of Cardiology (2016) | 1 Patient | Post-procedural | Mohan Ramachandran, Malaysia | |
| CR 06 | Inter-coronary communication in chronic total occlusion: in search of recognition | Summary | Know More | Indian Heart Journal (2016) | 1 Patient | - | 6 Months | Mohit Gupta, India |
| CR 05 | Chronic total occlusion intervention with no-flow tackled successfully | Summary | Know More | Journal of the American College of Cardiology (2015) | 1 Patient | - | Post-procedural | Arvind Kumar Kandoria, India |
| CR 04 | Ostial circumflex stenting through left main-LAD stent: a challenge of | Summary | Know More | Journal of the American College of Cardiology (2015) | 1 Patient | - | Procedural Details | Gurunath P. Parale, India |
| CR 03 | In-situ intra procedure left main coronary artery thrombosis | Summary | Know More | Journal of the American College of Cardiology (2014) | 1 Patient | - | Procedural Details | Puneet Verma, India |
| CR 02 | A percutaneous coronary intervention complication: coronary perforation | Summary | Know More | Journal of Turgut Ozal Medical Center (2013) | 1 Patient | - | Procedural Details | Abdulmek Yildiz, Turkey |
| CR 01 | IVUS guided stenting in moderate looking proximal coronary lesion | Summary | Know More | Journal of Indian College of Cardiology (2013) | 1 Patient | - | Post-procedural | Aniket Puri, India |
| Review Report/Scientific Reports (2) | ||||||||
| SR 02 | Comparison of over expansionvcapabilities and thrombogenicity at the | Summary | Know More | Nature (2020) | - | - | - | Pawel Gasior, Poland |
| SR 01 | BioMime a sirolimus-eluting coronary stent system for the treatment of | Summary | Know More | Interventional Cardiology Review, Research, Resources (2011) | 30 Patients | Prospective, single-arm, single-cente r study | 1 Year | Clinical Trial Department, Meril Life Sciences, India |
| Commentary (1) | ||||||||
| OR 01 | Very long stent technology: clinical and practical value | Summary | Know More | Future Cardiology (2013) | - | - | - | Ian Menown, United Kingdom |
| BioMime Branch™ Sirolimus Eluting Coronary Side Branch Stent System-Clinical Publication (Total = 3 articles) | ||||||||
| Original Research Article (2) | ||||||||
| OR 02 | Preliminary Assessment of a Dedicated Bifurcation Stent Using a Modified Technique in True Coronary Bifurcation Lesions: A Dual Centre Registry | Summary | Know More | Journal of Clinical Cardiology and Cardiovascular Interventions (2025) | 80 Patients | Prospective registry | Procedural | Raymundo Ocaranza-Sánchez, Mexico |
| OR 01 | Coronary Bifurcation Lesion Treatment with the BioMime™ Branch Sirolimus-Eluting Coronary Side-Branch Stent System: A Single-Center Experience | Summary | Know More | Cardiovascular Revascularization Medicine (2024) | 58 Patients | Retrospective, single-center study | 18 Months | Antonio L. Bartorelli, Italy |
| Abstract (1) | ||||||||
| AB 01 | BioMime™ Branch-1: a randomized comparison of sirolimus-eluting coronary side branch stent systems and everolimus-eluting stent systems to assess safety and performance in Patients with de novo coronary bifurcation lesions | Summary | Know More | EuroIntervention (2020) | 18 out of 24 Patients | Prospective, active-control, open-label, multi-center, randomized clinical trial | 6 Months | Sethuraman Selvamani, India |
| BioMime™ Morph Sirolimus Eluting Tapered Coronary Stent System- Clinical Publications (Total = 35 articles) | ||||||||
| Original Research Articles (14) | ||||||||
| OR 14 | Long-Term Safety and Performance of BioMime Morph Sirolimus-Eluting | Summary | Know More | AsiaIntervention (2025) | 448 Patients | Prospective, multi-center, single-arm, real-world, post-marketing Surveillance study | 3 Years | Deepak Davidson, India |
| OR 13 | Clinical outcomes of the BioMime™ Morph Coronary stent systme for long (30 to ≤ 56 mm length) coronary lesions: Three years follow-up of the Morpheus Global Registry. | Summary | Know More | Cardiovascular Revasecularization Medicine (2025) | 565 Patients | Prospective, single-arm, multicenter , observational, real-world registry | 3 Years | Pierfrancesco Agostoni, Belgium |
| OR 12 | Long-Term Safety and Performance of BioMime™ Morph Sirolimus-Eluting Coronary Stent System for Very Long Coronary Lesions | Summary | Know More | Cardiology Research (2024) | 88 Patients | Prospective, single-center, observational, real-world, post-marketing surveillance study | 3 Years | Suresh V. Patted, India |
| OR 11 | Real-world experience with a 60 mm long stent in the setting of primary percutaneous coronary intervention | Summary | Know More | Heart Views (2022) | 88 Patients | Retrospective, observational analysis | 1 Year | Babu Thevan, Kingdom of Bahrain |
| OR 10 | Percutaneous Intervention in Diffuse Coronary Disease: Overlapping Versus Single Very Long Stent Technique. Results From the OVERLONG Registry | Summary | Know More | Angiology (2021) | 678 Patients | Observational, retrospective, and single-center study | Median follow-up 31 months | Martín Negreira-Caamaño, Spain |
| OR 09 | One-year outcomes of novel BioMime™ Morph tapered stent in long and multiple coronary artery lesions | Summary | Know More | Anatolian Journal of Cardiology (2021) | 172 Patients | Observational, retrospective, single-center study | 1 Year | Yash Paul Sharma, India |
| OR 08 | Feasibility and outcomes of left main to branch vessel PCI with novel tapered coronary stent in a tertiary care center: a real-world experience | Summary | Know More | Cardiovascular and Hematological Disorders Drug Targets (2021) | 41 Patients | Prospective, non-randomised, single-centre study | Median follow-up 20 months | T.R.Raghu, India |
| OR 07 | Real-world experience with a tapered biodegradable polymer-coated sirolimus-eluting stent in Patients with long coronary artery stenosis | Summary | Know More | Cardiology Research (2020) | 272 Patients | Prospective, observational, and multi-centre study | 1 Year | Alessandro Lupi, Italy |
| OR 06 | Clinical experience with 12-month follow-up in Patients after implantation of a novel long tapered sirolimus drug-eluting stent | Summary | Know More | Advances in Interventional Cardiology (2019) | 32 Patients | Prospective clinical cohort study | 1 Year | Jakub Podolec, Poland |
| OR 05 | Feasibility of implanting 50-60 mm-tapered drug eluting stents in chronic total occlusions | Summary | Know More | Cardiovascular Revascularization Medicine (2019) | 51 out of 54 Patients | Retrospective, single-arm study | A median follow-up of 330 (149-551) days | Gema Miñana, Spain |
| OR 04 | Comparison of clinical outcomes between very long stents and overlapping stents for the treatment of diffuse coronary disease in real clinical practice | Summary | Know More | Cardiovascular Revascularization Medicine (2018) | 628 Patients | Single-centre, retrospective, observational study | Median follow-up of 20 months | Alfonso Jurado Román, Spain |
| OR 03 | Clinical outcomes of novel long-tapered sirolimus-eluting coronary stent system in real-world Patients with long diffused de novo coronary lesions | Summary | Know More | Cadiology Research (2018) | 362 Patients | Retrospective, non-randomized, multi-centre study | 1 Year | Suresh V. Patted, India |
| OR 02 | First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusion with the hybrid algorithm | Summary | Know More | Catheterization Cardiovascular Interventions (2018) | 49 out of 100 Patients | Observational retrospective study | 303 ± 179 Days | CarlZivelonghi, The Netherlands |
| OR 01 | First experience with the use of extra-long (40 to 60 mm) sirolimus-eluting stents in Patients with diffuse long | Summary | Know More | Kardilogiya (2017) | 85 Patients | Prospective, single - centre study | 1 Year | Yu G Matchin, Russia |
| Abstracts (8) | ||||||||
| AB 08 | Longitudinal stent deformation detected on coronary CT in the novel BioMime™ 60mm long sirolimus-eluting tapered stent | Summary | Know More | EuroIntervention (2020) | 20 Patients | Prospective, single-centre study | 6-9 Months | Silvia Homs, Spain |
| AB 07 | Clinical outcome of the world’s first tapered sirolimus eluting coronary stent system for long coronary lesions: a real-world experience | Summary | Know More | EuroIntervention (2020) | 435 Patients | Prospective, single-arm, multi-centre, real-world study | 1 Year | Deepak Davidson, India |
| AB 06 | First Experience with very long coronary drug eluting stent | Summary | Know More | Journal of the American College of Cardiology (2019) | 63 Patients | Retrospective study | 1-3 Months | Farhat Fouladvand, Italy |
| AB 05 | Initial experience with the novel BioMime™ Morph 40-60 mm long sirolimus-eluting tapered stent in long coronary lesions | Summary | Know More | EuroIntervention (2018) | 55 Patients | Prospective, single-centre study | 200 ± 50 Days | Anirban Choudhary, United Kingdom |
| AB 04 | Multicenter clinical outcomes of hybrid tapered sirolimus eluting coronary stent system with biodegradable polymer in long diffuse de novo coronary artery lesions | Summary | Know More | EuroIntervention (2018) | 362 Patients | Retrospective, multi-center, non-randomized study | 6 Months | Suresh V.Patted, India |
| AB 03 | Real World Experience of the BioMime™ Morph tapered stent in a Tertiary Care Hospital | Summary | Know More | Journal of the American College of Cardiology (2018) | 122 Patients | Retrospective observational study | 26 Months | Sanjai Pattu Valappil, India |
| AB 02 | Experience of the management of complex long lesion by Indigenous BioMime™ Morph tapering stents | Summary | Know More | Journal of the American College of Cardiology (2017) | 52 Patients | Prospective, observational study | 9 Months | Manotosh Panja, India |
| AB 01 | Long term outcome after revascularization of long coronary artery lesions with very long or overlapping stents. Insights from the propensity score matched registry | Summary | Know More | Journal of the American College of Cardiology (2017) | 123 out of 377 Patients | Prospective, multi-centre registry | 2 Years | Piotr Buszman, Poland |
| Case Reports (9) | ||||||||
| CR 09 | Use of BioMime™ Morph stent in treating left main triple vessel disease: a case report | Summary | Know More | The Egyptian Heart Journal (2020) | 1 Patient | - | 6 Months | Yash Paul Sharma, India |
| CR 08 | Successful treatment of tandem calcific right coronary artery stenoses with 50 mm tapered BioMime™ Morph stent guided by intravascular ultra sound and rotablation using a sheath less guide via the radial access | Summary | Know More | IHJ Cardiovascular Case Report (2019) | 1 Patient | - | 1 Year | Baskar Sekar, United Kingdom |
| CR 07 | Acute stent loss and its retrieval of a long, tapering Morph stent in a tortuous, calcified lesion | Summary | Know More | Cardiology Research (2018) | 1 Patient | - | Post-procedural | Santosh Kumar Sinha, India |
| CR 06 | Tapered stents in long diffusely diseased coronary arteries-our experience | Summary | Know More | Journal of the American College of Cardiology (2017) | 1 Patient | - | 2 Years | T.R. Raghu, India |
| CR 05 | The perfect storm | Summary | Know More | Journal of the American College of Cardiology (2017) | 1 Patient | - | Post-procedural | Jayakhanthan Kolanthaivelu, Malaysia |
| CR 04 | Management of long complex CTO in LCX by indigenous BioMime™ Morph tapering stents from Meril | Summary | Know More | Journal of the American College of Cardiology (2017) | 1 Patient | - | Post-procedural | Manotosh Panja, India |
| CR 03 | Intravascular ultrasonography guided 60-mm long drug eluting tapered stent implantation in a long-calcified lesion in a patient with stable coronary artery disease | Summary | Know More | Advances in International Cardiology (2017) | 1 Patient | - | Post-procedural | Jakub Podolec, Poland |
| CR 02 | First in Poland, unique 60-mm long single drug eluting tapered stent implantation in a patient with unstable angina | Summary | Know More | Polish Heart Journal (2017) | 1 Patient | - | Post-procedural | Jakub Podolec, Poland |
| CR 01 | A report of successful procedural, clinical, and angiographic outcomes with a tapered stent of a patient in naturally tapered coronary vessel | Summary | Know More | Journal of Clinical and Diagnostic Research (2017) | 1 Patient | - | 1 Year | Rajendra Kumar Premchand, India |
| Short Report (1) | ||||||||
| SR 01 | Initial Experience with the novel BioMime 60mm-long sirolimus-eluting tapered stent system in long coronary lesions | Summary | Know More | EuroIntervention (2017) | 50 Patients | Prospective clinical cohort study | Median follow-up 275 Days | Ernesto Valero, Spain |
| Commentary (1) | ||||||||
| C 01 | Innovative DES technologies from Meril | Summary | Know More | Minerva Cardiology and Angiology (2015) | - | - | - | Sanjeev Bhatt, India |
| Editorial (2) | ||||||||
| EL 02 | Gone long, not wrong: BioMime Morph and a tale of coronary ambition | Summary | Know More | Asia Intervention (2025) | - | - | - | Ignacio J. Amat-Santos, Spain |
| EL 01 | Treatment of long coronary lesions with single stent: BioMime Morph sirolimus-eluting tapered coronary stent system | Summary | Know More | Heart India (2018) | - | - | - | Suresh V. Patted, India |
| BioMime™ Aura Sirolimus Coronary Eluting Stent System-Clinical Publications (Total = 2 articles) | ||||||||
| Original Research Article (1) | ||||||||
| OR 01 | Endovascular reconstruction of popliteal and infrapopliteal arteries for limb salvage and wound healing in Patients with critical limb ischemia-A retrospective analysis | Summary | Know More | Indian Heart Journal (2016) | 34 Patients | Retrospective analysis | 3 Months | Uday B. Khanolkar, India |
| Case Report (1) | ||||||||
| CR 01 | Multiple coronary microfistulas between left anterior descending artery and left ventricle following myocardial infarction | Summary | Know More | Heart India (2017) | 1 Patient | - | Post-procedural | Sulaiman S, India |
| BioMime™ Lineage Sirolimus Eluting Coronary Stent System (Total = 1 articles) | ||||||||
| Case Report (1) | ||||||||
| CR 01 | Stent Crumpling as a Complication of Percutaneous Coronary Intervention, a Case Report and Literature Review | Summary | Know More | "Clinical Case Reports (2025)" | 1 Patient | - | Post-procedural | Maryam Mehrpooya, Iran |
| Evermine50™ EES-Drug Eluting Stent-Clinical Publications (Total = 14 articles) | ||||||||
| Original Research Articles (7) | ||||||||
| OR 07 | The ultrathin-strut everolimus-eluting stent in a real-world population: the Everythin multicenter registry | Summary | Know More | REC Interv Cardiol. 2025 | 161 patients | Prospective, non-randomized, multicenter study | 1 Year | "Juan Casanova-Sandoval, Spain" |
| OR 06 | Safety and efficacy of Evermine50 Everolimus-eluting coronary stent system in patients with native coronary artery lesions: Three-year outcomes from a single-center | Summary | Know More | Journal of Cardiovascular and Thoracic Research (2025) | 251 Patients | Prospective, post-marketing, single-center study | 3 years | Suresh V Patted, India |
| OR 05 | Clinical safety and performance of the world’s thinnest strut Evermine50™ Everolimus-eluting stent: A 24-month follow-up of Evermine50 EES-1 study | Summary | Know More | AsiaIntervention (2024) | 118 Patients | Prospective, single-arm, multi-center study | 2 Years | Sivaprasad K, India |
| OR 04 | Procedural safety and outcome of ultrathin strut stents (<60 μm) in the management of very long coronary artery stenosis (>30 mm)-A retrospective real-world study | Summary | Know More | American Journal of Cardiovascular Disease (2020) | 65 out of 156 Patients | Retrospective analysis, observational study | 8.4 ± 13.9 months mean follow up | Soumya Patra, India |
| OR 03 | Clinical outcomes of ultrathin strut biodegradable polymer coated everolimus eluting stent in Patients with coronary artery disease | Summary | Know More | ARYA Atherosclerosis (2020) | 171 Patients | Retrospective study, single-arm, all-comers, single-center study | 1 Year | Suresh V. Patted, India |
| OR 02 | Clinical safety and efficacy of world’s thinnest (50μm), very long (>40 mm) everolimus eluting stent among real world Patients | Summary | Know More | American Journal of Cardiovascular Disease (2020) | 711 Patients | Prospective, observational study | 1 Year | Santosh Kumar Sinha, India |
| OR 01 | Clinical outcomes of world’s thinnest (50μm) strut biodegradable polymer coated everolimus eluting coronary stent system in real-world Patients | Summary | Know More | Cardiology Research (2018) | 251 Patients | Prospective, single-arm, single-center, post marketing study | 6 Months | Suresh V. Patted, India |
| Editorial (2) | ||||||||
| EL 02 | Less is more: a new “thin-king” for DES? | Summary | - | AsiaIntervention (2024) | - | - | - | Azfar G. Zaman, United Kingdom |
| EL 01 | Biodegradable polymer Evermine50™ everolimus eluting coronary stent system with ultrathin (50μm) strut | Summary | - | Integrative Clinical Medicine (2018) | - | - | - | Suresh V. Patted, India |
| Case Series (1) | ||||||||
| CS 01 | Device embolization during trans-radial percutaneous coronary intervention: Various approaches.A case series | Summary | Know More | IHJ Cardiovascular Case Reports (2021) | 3 Patients | - | - | Nagamani Alur Chikkabasavaiah, India |
| Abstracts (4) | ||||||||
| AB 04 | One-year clinical outcomes of ultrathin strut everolimus eluting coronary system (50µm) for treatment of patient with de novo coronary artery lesions | Summary | Know More | AsiaIntervention (2019) | 171 Patients | Retrospective, single-arm, observational study | 1 Year | Suresh V. Patted, India |
| AB 03 | 1-year clinical outcomes after percutaneous coronary intervention with biodegradable polymer ultra-thin strut everolimus-eluting coronary stent system | Summary | Know More | Journal of the American College of Cardiology (2019) | 251 Patients | Prospective, single-arm, single-center, real-world study | 1 Year | Suresh V. Patted, India |
| AB 02 | Initial experience with ultrathin strut biodegradable polymer-coated everolimus-eluting coronary stent in coronary artery disease Patients | Summary | Know More | Journal of the American College of Cardiology (2018) | 110 Patients | Prospective, non-randomized, multi-center study | 6 Months | K. Sivaprasad, India |
| AB 01 | Clinical outcomes of ultrathin strut biodegradable polymer coated everolimus-eluting coronary stent system in treatment of patient with de novo coronary artery lesions | Summary | Know More | EuroIntervention (2018) | 171 Patients | Single-arm, single-center, non-randomized study | 1 Year | Suresh V. Patted, India |
| MeRes100™ Sirolimus Eluting BioResorbable Vascular Scaffold System- Clinical Publications (Total = 20 articles) | ||||||||
| Original Research Articles (5) | ||||||||
| OR 05 | A real-world experience with a thin-strut Bioresorbable vascular scaffold system: a single-centre study | Summary | Know More | AsiaIntervention (2025) | 86 Patients | Retrospective, single-centre study | 1 Year | Puneet K. Verma, India |
| OR 04 | Imaging and two-year clinical outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffold: | Summary | Know More | Catheterization and Cardiovascular Interventions (2020) | 64 Patients | Prospective, multi-centre, single-arm, open-label study | 2 Years | Alexandre Abizaid, Brazil |
| OR 03 | Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 trial | Summary | Know More | EuroIntervention (2019) | 108 Patients | Prospective, multi-center, single-arm, open-label clinical trial | 3 Years | Ashok Seth, India |
| OR 02 | Pharmacokinetic study of sirolimus-eluting bioresorbable vascular scaffold system for treatment of de novo native coronary lesions: a sub-study of MeRes-1 trial | Summary | Know More | Cardiology Research (2018) | 10 Patients | Prospective, single-arm, open-label pilot study | 90 days | Praveen Chandra, India |
| OR 01 | First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the | Summary | Know More | EuroIntervention (2017) | 108 Patients | Prospective, multi-center, single-arm study | 1 Year | Ashok Seth, India |
| Abstracts (9) | ||||||||
| AB 09 | The MeRes-1 Extend trial: 2-year clinical and 6-month imaging outcomes of thin-strut sirolimus-eluting BRS in Patients with de novo coronary artery lesions | Summary | Know More | Journal of the American College of Cardiology (2020) | 64 Patients | Prospective, multi-centre, single-arm study | Imaging follow-up at 6 months and clinical follow-up at 2 years | Alexandre Abizaid, Brazil |
| AB 08 | Clinical and imaging outcomes of thin-strut sirolimus eluting BRS in Patients with de novo coronary artery lesions: the MeRes-1 extend trial | Summary | Know More | EuroIntervention (2020) | 64 Patients | Prospective, multi-centre, single-arm study | Angiographic follow-up at 6 months and clinical follow-up upto 24 months | Alexandre Abizaid, Brazil |
| AB 07 | Implantation of thin-strut sirolimus-eluting bioresorbable vascular scaffold in Patients with de novo coronary artery lesions: 2-year clinical and 6-month imaging outcomes of the MeRes-1 extend trial | Summary | Know More | Journal of the American College of Cardiology (2019) | 64 Patients | Multi-centre, prospective, single-arm study | Imaging follow-up at 6 months and clinical follow-up at 2 years | Alexandre Abizaid, Brazil |
| AB 06 | Real world follow-up one year of the novel MeRes100 | Summary | Know More | Journal of the American College of Cardiology (2018) | 65 Patients (81 MeRes100 implanted) | Prospective, single-centre registry | 1 Year and OCT at 9 months | Marcos Ortega, Ecuador |
| AB 05 | Two-year clinical and imaging outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffolds in de novo coronary artery lesions: the MeRes-1 trial | Summary | Know More | Journal of the American College of Cardiology (2018) | 108 Patients | Prospective, multi-centre, single-arm study | 2 Years | Ashok Seth, India |
| AB 04 | Real world performance of the novel MeRes100™ | Summary | Know More | Journal of the American College of Cardiology (2017) | 34 Patients (41 MeRes100 implanted) | Prospective, single-centre, registry | 9 Months | Marcos Ortega, Ecuador |
| AB 03 | Favorable outcomes for systemic pharmacokinetic study of sirolimus-eluting bioresorbable vascular scaffold system in treating de novo native coronary artery lesion: A sub study of MeRes-1 Trial | Summary | Know More | Journal of the American College of Cardiology (2017) | 10 Patients | Prospective, multi-centre study | 90 Days | Ashok Seth, India |
| AB 02 | First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the treatment of de novo native coronary artery lesions: MeRes-1 trial | Summary | Know More | Journal of the American College of Cardiology (2017) | 108 Patients | Prospective, multi-centre, first-in-human study | Angiographic follow-up at 6-months, clinical follow-up at 12 months | Ashok Seth, India |
| AB 01 | Quantitative angiographic analysis in Patients with de novo native coronary artery lesions treated with novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 Trial | Summary | Know More | European Heart Journal (2017) | 108 Patients | First-in-man | Angiographic follow-up at 6-and 24 months | Ricardo Costa, Brazil |
| Review Articles (3) | ||||||||
| RA 03 | Fully bioresorbable vascular scaffolds: Lessons learned and future directions | Summary | Know More | Nature Reviews Cardiology (2019) | - | - | - | Hiroyuki Jinnouchi, United States of America |
| RA 02 | Bioresorbable coronary scaffolds: deployment tips and tricks and the future of the technology | Summary | Know More | Methodist DeBakey Cardiovascular Journal (2018) | - | - | - | J. Ribamar Costa, Brazil |
| RA 01 | Bioresorbable scaffold The emerging reality and future directions | Summary | Know More | Circulation Research (2017) | - | - | - | Yohei Sotomi, Netherlands |
| Book Chapter (1) | ||||||||
| BC 01 | MeRes100™ -A sirolimus eluting bioresorbable vascular | Summary | Know More | In Bioresorbable Scaffolds (2017) | - | - | - | Ashok Seth, India |
| Editorial/ Editorial Commentary (2) | ||||||||
| EL 02 | Can the vanishing stent reappear? Fix the technique, or fix the device? | Summary | Know More | Journal of the American College of Cardiology (2017) | - | - | - | Spencer B. King, USA |
| EL 01 |
| Summary | Know More | Indian Heart Journal (2017) | - | - | - | Sundeep Mishra, India |
| Mozec™ Rx PTCA Balloon Dilation Catheter- Clinical Publications (Total = 6 articles) | ||||||||
| Original Research Articles (3) | ||||||||
| OR 03 | Safety and Performance of the MOZEC Sirolimus-Eluting | Summary | Know More | Cardiology Research (2025) | 141 Patients | Prospective, single-arm, multi-centre, real-world, post-marketing surveillance study | 24 Months | Rajendra Kumar Premchand Jain,India |
| OR 02 | Clinical outcomes of a non-compliant balloon dilatation catheter: Mozec™ NC study | Summary | Know More | International Journal of Environmental Research and Public Health (2022) | 57 of 140 Patients | Post-marketing, single-centre, single-arm, retrospective study | 10.40 ± 0.26 months | Akshyaya Pradhan, India |
| OR 01 | Complex coronary interventions with the novel Mozec™ CTO balloon: The Mozart registry | Summary | Know More | Clinical Medicine Insights: Cardiology (2015) | 41 Patients | Prospective non- randomized, single-arm registry | 1 Year | Alessandro Lupi, Italy |
| Abstract (1) | ||||||||
| AB 01 | How to make a deal with distal left main coronary artery type a trifurcation lesion | Summary | Know More | Journal of the American College of Cardiology (2017) | 1 Patient | - | - | Yusra Pintaningrum, Indonesia |
| Review Article (1) | ||||||||
| RA 01 | Drug-coated balloons: technologies and clinical applications | Summary | Know More | Current Pharmaceutical Design (2018) | - | - | - | Huiying Ang, Singapore |
| Case Report (1) | ||||||||
| CR 01 | Persistent stent thrombosis in a patient with non-ST segment elevation myocardial infarction and mild COVID-19 | Summary | Know More | Journal of Coronary Artery Disease (2022) | 1 Patient | - | Procedural Details | Mehmet Rasih Sonsoz, Turkey |
| Metafor™ Sirolimus Eluting Coronary Stent System-Clinical Publications (Total = 5 articles) | ||||||||
| Original Research Articles (3) | ||||||||
| OR 03 | Twelve-month clinical outcomes of biodegradable polymer coated sirolimus-eluting coronary stent in real-world Patients: a single-center experience | Summary | Know More | Indian Heart Journal (2021) | 141 Patients | Retrospective, single-centre, post-marketing, observational study | 1 Year | Pankaj Jariwala, India |
| OR 02 | Safety and performance of sirolimus-eluting coronary stent system with biodegradable polymer: a retrospective analysis in real-world patient population | Summary | Know More | World Journal of Cardiovascular Diseases (2017) | 127 Patients | Retrospective, non-randomized, single-center study | 3.6 ± 0.6 Years | Vithala Surya Prakasa Rao, India |
| OR 01 | One-year clinical outcomes of biodegradable polymer coated sirolimus-eluting coronary stent system in Patients with coronary artery disease | Summary | Know More | World Journal of Cardiovascular Diseases (2017) | 251 Patients | Retrospective, single-center, observational, post-marketing study | 1 Year | Sridhar Kasturi, India |
| Abstracts (2) | ||||||||
| AB 02 | Safety and clinical performance of biodegradable polymer coated sirolimus-eluting coronary stent in real-world Patients | Summary | Know More | EuroIntervention (2020) | 141 Patients | Observational, single-center, post-marketing, retrospective study | 1 Year | Pankaj Jariwala, India |
| AB 01 | One-year clinical outcomes of biodegradable polymer coated sirolimus-eluting coronary stent system in Patients with coronary artery disease | Summary | Know More | Journal of the American College of Cardiology: Cardiovascular interventions (2017) | 251 Patients | Retrospective, single center, observational, post-marketing study | 1 Year | Shridhar Kasturi, India |
| NexGen™ Bare Metal Stent-Clinical Publication (Total = 1 articles) | ||||||||
| Original Research Articles (1) | ||||||||
| OR 01 | Evaluation of safety and efficacy of NexGen-an ultrathin strut and hybrid cell design cobalt-chromium bare metal stent implanted in a real-life patient population-the Polish NexGen™ Registry | Summary | Know More | Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej (2016) | 383 Patients | A prospective, multi-center registry | 1 Year | Krzysztof Milewski, Poland |
| Osum™ Cobalt Chromium Coronary Stent System-Clinical Publication (Total = 1 articles) | ||||||||
| Original Research Article (1) | ||||||||
| OR 01 | Clinical safety and performance of novel ultra-thin strut cobalt chromium bare metal stent implanted in real-world Patients with coronary artery disease | Summary | Know More | International Journal of Current Research (2018) | 467 Patients | Observational, non-randomized, retrospective, single-arm study | 2 Years | Mahesh Basarge, India |
| Dafodil™ Pericardial Bioprosthesis-Clinical Publications (Total = 3 articles) | ||||||||
| Original Research Articles (3) | ||||||||
| OR 03 | Outcomes of aortic and mitral valve replacement with Dafodil TM pericardial Bioprosthesis over 5-years: DafodilTM-1 trial | Summary | Know More | Frontiers in Cardiovascular Medicine (2026) | 136 Patients | first-in-human, prospective, multicenter study | 5-year | C.S. Hiremath, India |
| OR 02 | Three-year Outcomes of Surgical Valve Replacement with Dafodil™ Pericardial Bioprosthesis: Dafodil™-1 Trial | Summary | Know More | Frontiers in Cardiovascular Medicine (2024) | 136 Patients | First-in-human, prospective, multi-center study | 3 Years | C.S. Hiremath, India |
| OR 01 | Clinical outcomes and hemodynamic performance of Dafodil™ aortic and mitral pericardial bioprosthesis: 1-year results from Dafodil-1 first-in-human trial | Summary | Know More | Journal of Cardiothoracic Surgery (2020) | 60 Patients | First-in-human, prospective, single-arm, and multi-center trial | 1 Year | C.S. Hiremath, India |
| CREDENCE™ BtK Sirolimus Eluting Bioresorbable Peripheral Scaffold System-Clinical Publication (Total = 1 articles) | ||||||||
| Abstract (1) | ||||||||
| AB 01 | 12-month clinical outcomes of sirolimus-eluting bioresorbable peripheral scaffold system following percutaneous transluminal angioplasty of below-the-knee arteries in Patients with critical limb ischaemia: the CREDENCE™ BtK-1 study | Summary | Know More | EuroIntervention (2020) | 30 Patients | First-in-man, prospective, multi-centre and open-label study | 1 Year | Vimal Someshwar, India |
| Menox™ Liquid Embolic System-Clinical Publications (Total = 8 articles) | ||||||||
| Original Research Article (2) | ||||||||
| OR 02 | Comparison of a Novel Liquid Embolic System with Commonly Used Embolic Agents in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulas: A Single-Center Experience | Summary | Know More | Journal of Clinical Medicine (2024) | 11 out of 19 Patients | Single center, retrospective study | 12 Months | Zarko Nedeljkovic, Serbia |
| OR 01 | Intermixed dimethyl-sulfoxide based non adhesive liquid embolic agents delivered serially via the same micro catheter for cerebral AVM treatment | Summary | Know More | American Journal of Neuroradiology (2020) | 16 Patients | Single-centre, prospective study | Angiographic mean follow-up of 5.1 months | Alexander Sirakov, Bulgaria |
| Case Report (3) | ||||||||
| CR 03 | OPTEM-OHCM Optimal Targeted Polymer-based Embolization for Obstructive Hypertrophic Cardio Myopathy | Summary | Know More | JACC: Case Reports (2025) | 1 Patient | - | 1 Month | Evandro Martins Filho, Brazil |
| CR 02 | Embolization Using the Novel Menox Liquid Embolic System for Arteriovenous Fistulas: A Case Report | Summary | Know More | Journal of Clinical and Medical Image (2023) | 1 Patient | - | 6 Months | Audrius Sirvinskas, Lithuania |
| CR 01 | Endovascular treatment of a post-traumatic pseudoaneurysm arising from a ruptured posterior tibial artery with Menox™ A case report | Summary | Know More | Radiology Case Reports (2021) | 1 Patient | - | 6 Months | Christina Aslanidi, Greece |
| Case Series (2) | ||||||||
| CS 02 | Initial experience with the new ethylene vinyl alcohol copolymer based liquid embolic agent Menox™ in the endovascular treatment of cerebral arteriovenous malformations | Summary | Know More | Journal of NeuroInterventional Surgery (2018) | 24 Patients | Pilot study, retrospective analysis of prospectively collected data | 6 Months | Stanimir Sirakov, Bulgaria |
| CS 01 | Extending endovascular embolization to type A spinal peri-medullary arteriovenous fistula using liquid embolic agent: technical nuances, challenges and initial outcomes | Summary | Know More | World Neurosurgery (2018) | 3 Cases | - | - | Virender Malik, India |
| Review Article (1) | ||||||||
| RA 01 | Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas | Summary | Know More | Clinical Neuroradiology (2022) | - | - | - | Dominik F. Vollherbst, Germany |
| Obtura™Vascular Closure Device- Clinical Publication (Total = 4 articles) | ||||||||
| Original Research Article (3) | ||||||||
| OR 03 | From Compression to Closure: Efficacy and Safety of Vascular Closure Devices (VCD) Versus Manual Compression: A Comparative Analysis of Hemostatic Strategies of Obtura, Angioseal, and ProGlide VCD | Summary | Know More | Journal of the Saudi Heart Association (2026) | 250 of 1000 patients | Prospective, stratified random control study | Post procedure | Kumar Himanshu, India |
| OR 02 | Safety & Effectiveness of the Obtura 8F Vascular Closure Device in Neuro-Interventional Practice: A Retrospective Analysis | - | Know More | Vascular and Endovascular Surgery (2026) | 100 Patients | Retrospective, single-center, observational study | 30 Days and Months | Rasmiranjan Padhi, India |
| OR 01 | Comparing Obtura Vascular Closure Device to Manual Compression for Achieving Hemostasis After Percutaneous Transfemoral Procedures: A Randomized Study | Summary | Know More | Journal of Endovascular Therapy (2024) | 134 out of 268 Patients | Prospective, randomized, controlled, multi-center trial | 3 Months | Tom Devasia, India |
| Case Report (1) | ||||||||
| CR 01 | Direct Carotid Puncture Mechanical Thrombectomy in Medium Vessel Occlusion (MEVO) Stroke Using Obtura Closure Device for Hemostasis | - | Know More | Vascular and Endovascular Surgery (2025) | 1 Patient | - | 2 weeks | Rasmiranjan Padhi, India |
| Mammoth Balloon Catheter-Clinical Publication (Total = 1 articles) | ||||||||
| Original Research Articles (1) | ||||||||
| OR 01 | Performance of the Mammoth Balloon Catheter in Patients with Severe Aortic Valve Stenosis Undergoing Percutaneous Treatment | Summary | Know More | Journal of Clinical Medicine (2024) | 121 Patients | Retrospective, single-center cohort analysis | Post-procedure | Silvia Moscardelli, Italy |
| Miltonia bi-leafet Mechanical Heart Valve- Clinical Publication (Total = 2 articles) | ||||||||
| Original Research Articles (2) | ||||||||
| OR 02 | Clinical experience with the miltonia valve: short-term performance of new bi-leafet mechanical prosthesis in mitral valve replacement surgery | Summary | Know More | Indian Journal of Thoracic and Cardiovascular Surgery (2024) | 50 Patients | Prospective observational study | 6 Months | Nitin Kumar Kashyap, India |
| OR 01 | Clinical Outcomes of Percutaneous Transcatheter Release of Stuck Mechanical Mitral Valve With Cerebral Embolic Protection | Summary | Know More | Circulation: Cardiovascular Interventions (2024) | 4 out of 24 Patients | Retrospective single-center study | Median 344.50 days | Vasu Nandhakumar, India |
| ORTHOPEDIC (Total = 58 articles) | ||||||||
| Opulent bionik Gold knee - Clinical Publication (Total = 4 articles) | ||||||||
| Original Research Articles (2) | ||||||||
| OR 02 | Assessment of Patellofemoral Overstuffing on the Results of Total Knee Arthroplasty: An Observational Prospective Study | Summary | - | The Max Medical Journal (2024) | 214 Patients | Prospective observational study | 3 and 6 Months | Simon Thomas |
| OR 01 | Robotic Total Knee Replacement: Our Experience with First 200 Knees | Summary | - | The Max Medical Journal (2024) | 200 Patients | Cohort study | 3 Weeks, 6 Weeks, 3 Months | Anil Arora, India |
| Case Report (1) | ||||||||
| CR 01 | Total Knee Replacement for Varus Deformity in Osteoarthritis of Knee with Multiple Hereditary Exostoses – A Rare Case Report | Summary | - | Journal of Orthopedic Case Report (2025) | 1 Patients | - | 1 Year | Chaitanya Vyawahare India |
| Case Series (1) | ||||||||
| CS 01 | Stress Fracture of the Femoral Neck Following Total Knee Arthroplasty: A Case Series | Summary | - | Cereus (2023) | 5 Patients | Retrospective Case series | 6 Months | Anil Arora, India |
| MISSO Active Robotic System/Latitud Hip Replacement/Freedom® Total Knee System/ DESTIKNEE®/Opulent ™ Total Knee System (Total = 1 articles) | ||||||||
| Editorial (1) | ||||||||
| EL 01 | Rise of Revision Arthroplasties in Indian Subcontinent: An Inadvertent Future | Summary | - | Journal of Orthopaedic Case Reports (2025) | - | - | - | Kunal Aneja, India |
| Freedom® Total Knee System (Total = 20 articles) | ||||||||
| Original Research Articles (16) | ||||||||
| OR 16 | A Prospective Multicenter Analysis of the Midterm Outcomes of Component Size Variation in Simultaneous Bilateral Total Knee Arthroplasty: Does One-Size Difference Matter? | Summary | Know More | Cureus (2025) | 166 Patients | Prospective Subset analysis, Multicenter study | 6 weeks, 6 months, 1-year, 3-year | Haresh P. Bhalodiya, India |
| OR 15 | Mid-term Outcomes of Patella Resurfacing During Total Knee Arthroplasty (TKA): Clinical, Functional, and Radiographic Insights | Summary | Know More | Cureus (2024) | 74 Patients | Prospective, multicenter, single-arm, real-world study | 3 Years | Supreet Bajwa, India |
| OR 14 | An Early Experience with a Novel Technique of Total Knee | Summary | Know More | Indian Journal of Orthopaedics (2022) | 3 Patients | Retrospective analysis | 2 Years | Sanjay Bhalchandra Londhe, India |
| OR 13 | Evaluation of the safety and efficacy of the fully automated active robotic system in robotic-assisted total knee arthroplasty | Summary | Know More | Journal of Clinical Orthopaedics and Trauma (2023) | 30 Patients | Single-center, prospective study | 6 Months | Sanjay Bhalchandra Londhe, India |
| OR 12 | Continuation of a Currently Available Primary Total Knee Arthroplasty System Design: 10-Year Follow-Up of Earlier Studies at 2- and 5-Years | Summary | Know More | Journal of Orthopaedic Experience & Innovation (2024) | 172 Patients | Prospective study | 10 Years | Sridhar Durbhakula, India, |
| OR 11 | Comparative mid-term evaluation of unilateral and bilateral total knee arthroplasty utilizing metal-backed | Summary | Know More | Journal of Orthopaedic Reports (2025) | 408 Patients | Prospective, single-arm post-marketing surveillance study | 3 Years | Ponnanna Karineravanda Machaiah, India |
| OR 10 | Comparison of Early Results Between Bone-Conserving | Summary | Know More | Journal of Orthopedic Research and Therapy (2024) | 280 Patients in Freedom TKA group | Prospective study | Mean follow up of 3.5 years (range, 2 to 5 years) | Young-Hoo Kim, Republic of Korea |
| OR 09 | A comprehensive comparative study on mid-term clinical and functional outcomes in Indian patients following bilateral total knee arthroplasty: assessing the impact of body mass index on post-total knee arthroplasty results | Summary | Know More | International Journal of Research in Orthopaedics (2024) | 190 Patients | Prospective, multi-center observational study | 3 Years | Karineravanda M. Ponnanna, India |
| OR 08 | Age wise comparative analysis of Patients undergoing total knee arthroplasty: a multicenter indigenous experience | Summary | Know More | International Journal of Research in Orthopaedics (2024) | 300 Patients | Prospective, multi-centre, real-world study | 3 Years | Ravi Teja Rudraraju, India |
| OR 07 | A multi-centre retrospective study of the impact of body mass index on clinical and functional outcomes of total knee arthroplasty: An Indian prospective | Summary | Know More | Journal of Orthopaedic Reports (2024) | 259 Patients | Multi-centre retrospective analysis | 3 Years | Kunal Arneja, India |
| OR 06 | Efficacy of the pre‑operative three‑dimensional (3D) CT scan templating in predicting accurate implant size and alignment in robot | Summary | Know More | Indian Journal of Orthopaedics (2022) | 30 Patients | Prospective, single-center study | - | Sanjay Bhalchandra Londhe, India |
| OR 05 | Early results of bone‑conserving high flexion posterior‑stabilized total knee system in Indian population | Summary | Know More | Indian Journal of Orthopaedics (2022) | 208 Patients | Prospective, continuous series study | 5 Years Average follow-up (years): 7.15 ± 1.23 (n = 208) | Sanjay Bhalchandra Londhe, India |
| OR 04 | Education, engagement, and provision of empathy by trained counselor enhances the patient satisfaction after | Summary | Know More | Journal of Clinical Orthopaedics and Trauma (2020) | 200 Patients | Prospective, randomized study | 52 Weeks | Sanjay Bhalchandra Londhe, India |
| OR 03 | Restoration of femoral condylar anatomy for achieving optimum functional expectations: continuation of an earlier study at 5-year minimum follow-up | Summary | Know More | Reconstructive review (2019) | 172 Patients | Prospective, single-center study | 5 Years | Sridhar Durbhakula, India |
| OR 02 | Clinical evaluation of efficacy and performance of all-poly tibial Freedom® total knee system for treating osteoarthritis Patients: three-year follow up study | Summary | Know More | Journal of Clinical and Diagnostic Research (2017) | 158 Patients | Retrospective, post-marketing study, single-center | 3 Years | Avatar Singh, India |
| OR 01 | Restoration of femoral condylar anatomy for achieving optimum functional expectations: component | Summary | Know More | Reconstructive review (2016) | 172 Patients | Prospective, non-randomized, single-center study | 2 Years with average follow-up of 3.8 ± 0.9 Years | Sridhar Durbhakula, India |
| Commentary (1) | ||||||||
| C 01 | Challenges in successful management of haemophilic knee arthropathy: our experience in a tertiary center | Summary | Know More | Journal of Orthopaedics (2022) | 24 Patients | Retrospective chart review | 1 Year | Mohan Thadia, India |
| Abstract (3) | ||||||||
| AB 03 | Can the subvastus approach for total knee arthroplasty help in achieving high flexion in highflex knees? Results of 242 knees at four years | Summary | Know More | Orthopaedic Proceedings (2019) | 184 Patients | Retrospective, observational, real-world study | Mean follow-up 3.71 ± 0.98 Years | Nilen Shah, India |
| AB 02 | Component size discrepancies and their influence on three-year outcomes in simultaneous bilateral total knee arthroplasty: A multicentral prospective study | Summary | Know More | Journal of Clinical Orthopaedics and Trauma (2024) | 166 Patients | Multicenter , Prospective Study | 3 years | Kunal Aneja, India |
| AB 01 | One-stage total knee arthroplasty with long stemmed tibia for traumatic tibial diaphysis fracture with co-existing osteoarthritis of the knee | Summary | Know More | Orthopaedics Proceedings (2022) | 3 Patients | - | 1 Year | Sanjay Bhalchandra Londhe, India |
| Cuvis Joint- Clinical Publications (Total = 19 articles) | ||||||||
| Original Research Articles (18) | ||||||||
| OR 18 | Does Resident Rotation Affect the Learning Curve of Active Robotic TKA? A Study of Surgical Efficiency and Radiographic Precision | Summary | Know More | Medicina (2026) | 60 Patients | Prospective cohort study | Postprocedure | Yong-Beom Park, Republic of Korea |
| OR 17 | Coronal alignment in Indian osteoarthritic knees: Predominance of varus apex-distal phenotypes highlights population-specific alignment patterns | Summary | Know More | Journal of ISAKOS (2026) | 604 Patients | Single-center, Retrospective radiographic study | 6 months | Madan Mohan Reddy, India |
| OR 16 | Robotic-Assisted Dynamic Intraoperative Assessment of Coronal Plane Stability Across the Range of Motion During Total Knee Arthroplasty | Summary | Know More | Journal of Orthopedic Case Reports (2026) | - | Prospective study | - | Rajashekhar K T, India |
| OR 15 | Impact of femoral component flexion on gap balancing in varus knees using robotic technology: a comparative study of single‑radius and multi‑radius designs | - | Know More | Journal of Robotic Surgery (2025) | 200 patients | Prospective observational cohort study | Ratnakar Vecham, India | |
| OR 14 | Accuracy and Consistency of Active Robotics in Correcting Coronal (Varus/Valgus) and Sagittal (Fixed Flexion Deformity/Hyperextension) Plane Deformities in Total Knee Arthroplasty | - | Know More | Indian Journal of Orthopedics (2025) | 234 Patients | Single-center retrospective study | Post-operative | Shailendra Patil, India |
| OR 13 | Achieving Accuracy and Gap Balancing in Fully Autonomous RoboticAssisted Total Knee Arthroplasty with Functional Alignment in Valgus Knee Deformity | Summary | Know More | Journal of Orthopedic Case Reports (2025) | 50 Patients | Retrospective matched-cohort observational study | - | Rajashekhar K T , India |
| OR 12 | Trends in adoption of robotics in arthroplasty: an analysis of the Indian landscape | - | Know More | Journal of Robotic Surgery (2025) | - | Cross-sectional observational study | - | Praharsha Mulpur , India |
| OR 11 | Analysis of the Transepicondylar Angle in the Indian Population: A Single-Centre Study Using CUVIS Robot and Computed Tomography Scan Data | Summary | Know More | The Max Medical Journal (2025) | 200 Patients | Retrospective study | - | Lakshay Goel, India |
| OR 10 | Evaluating the accuracy of Cuvis™ robot assisted total knee arthroplasty using offset type tensor system in ligament gap balancing | - | Know More | Journal of Clinical Orthopedics and Trauma (2025) | 159 Knees | Prospective single-center study | - | Woon-Hwa Jung, South Korea |
| OR 09 | Gap Balancing Technique With Functional Alignment in Total Knee Arthroplasty Using the Cuvis Joint Robotic System: Surgical Technique and Functional Outcome | Summary | Know More | Cureus (2025) | 360 Patients | Prospective study | 1, 3, and 6 months | Rajashekhar K T , India |
| OR 08 | Robotic Total Knee Replacement: Our Experience with First 200 Knees | Summary | Know More | The Max Medical Journal (2024) | 200 Patients | Cohort Study | 3 weeks, 6 weeks, 3 months | Anil Arora, India |
| OR 07 | Correlation Between Planned and Executed Bone Cuts Using Robotics in Total Knee Arthroplasty: A Prospective Study of 500 Patients | - | Know More | Indian Journal of Orthopedics (2024) | 500 Patients | Prospective single-center study | - | Neeraj Adkar , India |
| OR 06 | Minimized Soft Tissue Release in Robotic-Assisted Total Knee Arthroplasty: A Retrospective Review of 100 Cases | Summary | Know More | Cureus (2024) | 100 Patients | Retrospective analysis | Post-procedural | Sanjay B. Londhe, India |
| OR 05 | Assessment of average femoral component rotation for balancing functionally aligned total knee replacement in varus deformity: Robotic image guidance study | Summary | Know More | Journal of Orthopaedics (2024) | 40 Patients | Prospective study | 3 Months | Harish Kumar Murugesan, India |
| OR 04 | Analysis of robot-specific operative time and surgical team anxiety level and its effect on alignment during robot-assisted TKA | Summary | Know More | Journal of Robotic Surgery (2024) | 40 Patients | Prospective, single-center study | Post-procedural | Sanjay Bhalchandra Londhe, India |
| OR 03 | Comparison of Time Taken in Conventional versus Active | Summary | Know More | Clinics in Orthopedic Surgery (2024) | 30 Patients | Prospective study | 30 Days | Sanjay Bhalchandra Londhe, India |
| OR 02 | Intra-operative Safety of an Autonomous Robotic | Summary | Know More | Indian Journal of Orthopaedics (2023) | 500 Patients | Single-center, retrospective, observational study | Minimum 3 Months | Chandrashekar P, India |
| OR 01 | Efficacy of the Pre-operative Three-Dimensional (3D) CT | Summary | Know More | Indian Journal of Orthopaedics (2023) | 30 Patients | Prospective study, single-center study | Post-procedural | Sanjay Bhalchandra Londhe, India |
| Review Article (1) | ||||||||
| RA 01 | The role of next ‑generation robotic systems in transforming knee arthroplasty: precision and beyond (MISSO is also included in this article) | - | Know More | Journal of Robotic Surgery (2025) | - | - | - | Ravi Teja Rudraraju, India |
| Latitud Hip Replacement- Clinical Publications (Total = 9 articles) | ||||||||
| Original Research Articles (6) | ||||||||
| OR 06 | Mid-term Outcomes of Patella Resurfacing During Total Knee Arthroplasty (TKA): Clinical, Functional, and Radiographic Insights | Summary | Know More | Cureus (2024) | 74 | Prospective, multicenter, single-arm, real-world study | 3 Years | Supreet Bajwa |
| OR 05 | Safety and Functional Outcomes Following Total Hip Arthroplasty Using the Latitud™ Total Hip Replacement System in Patients With Hip Fracture | Summary | Know More | Cureus (2025) | 44 patients | Prospective, multi-center, post-marketing surveillance study | At 6 weeks, 6 months,1 and 2 year | Ponnanna Machaiah, India |
| OR 04 | Total Hip Arthroplasty for Osteonecrosis of the Femoral Head: A Mid-term Follow-Up in Patients From Northern India | Summary | Know More | Cureus (2024) | 84 Patients | Prospective, single-center, observational study | 4 Years | Naman Parakh, India |
| OR 03 | Safety and Efficacy of Latitud™ Hip Replacement in | Summary | Know More | Research Square Pre-print (2024) | 150 Patients | Retrospective, single-centre, post-market, observational study | 1 Year | Olzhas Bekarissov, Kazakhstan |
| OR 02 | Cemented bipolar hemiarthroplasty for unstable intertrochanteric fracture in elderly patients over 70 years: Boon or bane? | Summary | Know More | European Journal of Orthopaedic Surgery & Traumatology (2024) | 37 Patients | Retrospective single-centre study | 12 Months | Bushu Harna, India |
| OR 01 | Functional and clinical outcome with modified lateral approach total hip arthroplasty in stiff hips with ankylosing spondylitis | Summary | Know More | World Journal of Orthopedics (2022) | 40 Patients | Retrospective Cohort Study | 38.33 Months mean follow-up | Mathew Kiran Jacob, India |
| Case Reports (3) | ||||||||
| CR 03 | Harnessing 3D Printing Technology for Complex Acetabular Reconstruction in Revision Total Hip Arthroplasty: From Childhood Hip Trauma to Customized Modern Solutions | Summary | Know More | Journal of Orthopedic Case Reports (2026) | 1 Patient | - | 6 Months | J S R G Saran, India |
| CR 02 | Ochronotic arthropathy of the hip with multiple joint involvement: a rare case report and literature review | Summary | Know More | The Egyptian Orthopaedic Journal (2024) | 1 Patient | - | 6 Months | Plaban N. Chowdhuy, India |
| CR 01 | Partial replacement of pelvis with the hip joint in osteosarcoma treatment: A case report | Summary | Know More | Annals of Medicine and Surgery (2021) | 1 Patient | - | 6 Months | Dung Tran Trung, Vietnam |
| Destiknee- Clinical Publication (Total = 5 articles) | ||||||||
| Original Research Articles (4) | ||||||||
| OR 04 | Mid-term to long-term survivorship and functional outcomes of the Meril DestikneeTM posterior-stabilized system in primary TKA | - | Know More | The Knee (2026) | 1109 Patients | Retrospective observational study | 10 Years (mean follow-up 7.63 years) | Kushal Hippalgaonkar, India |
| OR 03 | An investigation into the cellular-level adverse effects of tourniquet use on the infrapatellar fat pad in primary total knee arthroplasty: A prospective randomized study | Summary | Know More | Acta Orthopaedical et Traumatological Turcica (2023) | 58 Patients | Prospective, randomized controlled study | 3 Months | Recep Altin, Turkey |
| OR 02 | A study to assess the clinical and functional outcome of sub-vastus approach for total knee arthroplasty | Summary | Know More | International Journal of Research in Orthopaedics | 30 Patient | Prospective and observational study | 1 Year | Tarun Gupta, India |
| OR 01 | An investigation into the cellular-level adverse effects of | Summary | Know More | ACTA ORTHOPAEDICA et TRAUMATOLOGICA TURCICA (2023) | 58 patients | Prospective randomized controlled study | 3 months | Recep Altin, Turkey |
| Case Report (1) | ||||||||
| CR 01 | Erosion and Failure of the Tibial Post after Posterior-stabilized Total Knee Replacement: A Case Report | Summary | Know More | Journal of Orthopaedic Case Reports (2023) | 1 Patient | - | 12 Months | Sneh Shah,India |
| ENDOSURGERY (Total = 20 articles) | ||||||||
| MITSU™ ABP Polyglactin 910 Suture-Clinical Publications (Total = 6 articles) | ||||||||
| Study Protocol (1) | ||||||||
| SP 01 | Evaluation of safety and efficacy of Polyglactin 910 suture in surgical incision closure: clinical study protocol for a randomized controlled trial | Summary | Know More | International Journal of Clinical Trials (2018) | 122 Patients | Prospective, multi-center, randomized, controlled, comparative, post-marketing and single-blinded | 6 Months | Asha Dixit, India |
| Original Research Articles (5) | ||||||||
| OR 05 | Efficacy and Safety of MITSU AB™ TriclosanCoated Sutures in Preventing Surgical Site Infections | Summary | Know More | Cureus (2025) | 60 Patients | Prospective, single-arm, multi-center, observational study | Postoperative, 7, 15, and 30 days | Pushkar Galam, India |
| OR 04 | Comparison of bacterial colonization on absorbable non-coated suture with Triclosan- or Chlorhexidine-coated sutures: a randomized controlled study | Summary | Know More | European Review for Medical and Pharmacological Sciences (2023) | 75 Patients | Randomized controlled double-blinded study | Post-operative | S. Chaganti, India |
| OR 03 | Comparison of surgical site infection rate between antibacterial coated surgical suture and conventional suture: a randomized controlled single centre study for preventive measure of postoperative infection (MITSU AB™ and MEGASORB-T+) | Summary | Know More | International Journal of Pharmaceutical Sciences and Research (2019) | 110 Patients | Single-center, randomized controlled trial | 30 Days | Probin Kr. Roy, India |
| OR 02 | An analysis of synthetic absorbable sutures using solid-state NMR and DSC | - | Know More | Journal of Medical Biomedical and Applied Sciences (2019) | - | - | - | Anish Desai, India |
| OR 01 | Safety and Efficacy of triclosan-coated polyglactin 910 suture in prevention of surgical site infection in postpartum women: A randomized controlled trial | Summary | Know More | Journal of the Indian Medical Association (2018) | 122 patients | Prospective, multicenter, single-blinded (Patient blinded), randomized controlled trial | 6 Months | Asha Dixit, India |
| Mirus™ Circular Stapler- Clinical Publications (Total = 3 articles) | ||||||||
| Original Research Article (2) | ||||||||
| OR 02 | Clinical outcomes of stapled hemorrhoidopexy using a novel three-row stapler for grade III/IV hemorrhoids: A single-center experience with literature review | Summary | Know More | Journal of Clinical Images and Medical Case Reports (2023) | 77 patients | A single centre study | 2 years | M Sadiq Kazi, India |
| OR 01 | Our initial experience of three versus two rows circular stapler devices for stapled hemorrhoidopexy: a single institution review of 224 cases | Summary | Know More | International Surgery Journal (2020) | 224 Patients | Retrospective, observational, cohort study | - | Paritosh Gupta, India |
| Study Protocol Clinical Trial (1) | ||||||||
| SPCT 01 | Uni-center, patient-blinded, randomized, 12-month, parallel group, non-inferiority study to compare outcomes of 3-row vs 2-row circular staplers for colorectal anastomosis formation after low anterior resection for rectal cancer | Summary | Know More | Medicine (2019) | 154 Patients | Prospective, non-inferiority, 2-armed, parallel-group | - | Nikita A. Nekliudov, Russia |
| MIRUS™ Disposable Haemorrhoids Stapler- Clinical Publications (Total = 1 articles) | ||||||||
| Original Research Articles (1) | ||||||||
| OR 01 | Comparison of conventional (CH) vs stapled haemorrhoidectomy (SH): three-yearss experience | Summary | Know More | Annals of International Medical and Dental Research (2017) | 150 Patients | Retrospective and comparative study | 1 Year | Kumar Gaurav, India |
| Fiona™ Intrauterine Contraceptive Device-Clinical Publication (Total = 1 articles) | ||||||||
| Original Research Article (1) | ||||||||
| OR 01 | Safety and performance of a levonorgestrel-releasing intrauterine contraceptive device: one-year outcomes of Fiona-1 clinical registry | Summary | Know More | Journal of the Indian Medical Association (2019) | 309 Patients | Prospective, open-label, single-arm post-marketing study | 1 Year | Jagruti Desai, India |
| Filaprop Mesh and Filaprop Mesh Soft Hernia Repair Solutions Tissue Separating Dual Layer Mesh (01) (Total = 1 articles) | ||||||||
| Original Research Articles (1) | ||||||||
| OR 01 | Long-Term Safety and Clinical Outcomes of Filaprop™ Mesh Variants in Elective Hernia Repair: A Multicenter Study | Summary | Know More | Indian Journal of Surgery (2025) | 651 patients | Retrospective, multicenter, observational study | 1,3,5, and 7year | Tushar Dixit, India |
| FILASILK™ Silk Suture-Clinical Publication (Total = 1 articles) | ||||||||
| Original Research Article (1) | ||||||||
| OR 01 | The safety and efficacy of clipless versus conventional laparoscopic cholecystectomy-our experience in an Indian rural center | Summary | Know More | MAEDICA Journal of Clinical Medicine (2018) | 160 Patients | Prospective study | 2 Months | Rikki Singal, India |
| Filaprop™ 3D Mesh Hernia Repair Solutions Polypropylene Mesh (01) (Total = 3 articles) | ||||||||
| Original Research Articles (2) | ||||||||
| OR 02 | The effect of absorbable vs. non-absorbable fixation on early complications in laparoscopic transabdominal preperitoneal (TAPP) inguinal herniorrhaphy | - | Know More | Annals of Medical Research (2024) | 44 Patients | Prospective Study | 1 st week, 1 month and 6 months | Mustafa Hilkat Bilaloglu, Turkey |
| OR 01 | Is mesh fixation necessary in laparoendoscopic techniques for M3 inguinal defects? An experimental study | Summary | - | Surgical Endoscopy (2023) | - | Experimental Study | - | Mateusz Zamkowski, Poland |
| Study Protocol (1) | ||||||||
| SP 01 | MEsh FIxation in Laparoendsocopic Repair of Large M3 inguinal hernias: multicenter, double-blinded, randomized controlled trial-study protocol for a MEFI Trial | Summary | Know More | Zamkowski and Śmietański Trials (2023) | - | - | - | Mateusz Zamkowski, Poland |
| MEGASORB™ Polyglycolic Acid Suture | MEGASORBPLUS™ Polyglycolic Acid Suture with Chlorhexidine | MEGASORB RAPID™ Polyglycolic Acid Suture (Total = 2 articles) | ||||||||
| Original Research Article (2) | ||||||||
| OR 02 | Comparative Evaluation of the Efficacy of Triclosan‑Coated and Chlorhexidine‑Coated Suture on Bacterial Load Reduction in Periodontal Flap Surgery: A Clinicomicrobiological Study | - | Know More | Journal of Pharmacy and Bioallied Sciences (2025) | 20 Patients | Prospective, randomized, double‑blind trial | Post-operative | Megha Choudhary, India |
| OR 01 | Comparative evaluation of two antibacterial-coated resorbable sutures versus non coated resorbable sutures in periodontal flap surgery: A clinico-microbiological study | Summary | Know More | Indian Society of Periodontology (2019) | Total 30 Patients. 10 patients with each suture | Randomized controlled double-blinded study | 1 Month | Prerna Ashok Karde, India |
| ABSOMESH™ Polyglecaprone 25/ Polypropylene Mesh-Clinical Publication (Total = 1 articles) | ||||||||
| Original Research Article (1) | ||||||||
| OR 01 | A comparative study of open vs laparoscopic repair in umbilical and para umbilical hernias | Summary | Know More | Journal of Dental and Medical Sciences (2019) | 70 out of 156 Patients | Prospective, observational study | Post-operative | P. Venkata Buddha, India |
| MERIZELLE Absorbable Hemostat- Clinical Publication (Total = 1 articles) | ||||||||
| Original Research Articles (1) | ||||||||
| OR 01 | The Safety and Effectiveness of MERIZELLE Oxidized Regenerated Cellulose in Achieving Hemostasis Across Various Surgical Procedures-A Prospective, Multi-Center, Post-Marketing Surveillance Study | Summary | Know More | Journal of Wound Care (2024) | 189 Patients | Prospective, Multi-Center, Post-Marketing Surveillance Study | 6 Months | Amey Patankar, India |
| DIAGNOSTICS (Total = 3 articles) | ||||||||
| ABFIND COVID-19 Neutralizing Antibody Rapid Test-Clinical Publication (Total = 1 articles) | ||||||||
| Original Research Article (1) | ||||||||
| OR 01 | A prospective, single-center study to evaluate the clinical performance of Meril ABFind in individuals vaccinated against Covid-19 | Summary | Know More | medRxiv (Preprint) (2022) | 62 Patients | Single centre, prospective study | - | Jayanti Shastri, India |
| EXIMO™ Blood Glucose Monitoring System-Clinical Publication (Total = 1 articles) | ||||||||
| Original Research Article (1) | ||||||||
| OR 01 | A post-marketing surveillance study to evaluate performance of the EXIMO™ blood glucose monitoring system | Summary | Know More | Journal of Clinical and Diagnostic Research (2017) | 1005 Patients | Non-randomized, single-center, post-marketing study | - | Sonia R. Chandnani, India |
| CelQuant 360™ Automated Haematology Analyser-Clinical Publication (Total = 1 articles) | ||||||||
| Original Research Article (1) | ||||||||
| OR 01 | Comparison between haematological parameters by the Merilyzer Celquant 360™ automated haematology analyser and Sysmex XP-100 haematology analyser with them manual methods | - | - | European Journal of Biomedical and Pharmaceutical Sciences (2018) | ||||




